1. Ikezaki H, Furusyo N, Ihara T, Hayashi T, Ogawa E, Toyoda K, Taniai H, Kainuma M, Murata M, Hayashi J.
Abbott RealTime PCR assay is useful for evaluating virological response to antiviral treatment for chronic hepatitis C.
Journal of Infection and Chemotherapy, 2011;17(6): 737-43
[PMID: 21528383, DOI:10.1007/s10156-011-0249-7]

2.Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J.
Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS).
Diabetologia, 2011; 54(12): 3028-36
[PMID: 21947435, DOI:10.1007/s00125-011-2310-6]

3.Furusyo N, Murata M, Ogawa E, Toyoda K, Ihara T, Ikezaki H, Hayashi T, Koga T, Kainuma M, Hayashi J.
Ribavirin concentration in the later stages of 48 week pegylated interferon-α2b plus ribavirin therapy for chronic hepatitis C is useful for predicting virological response.
Journal of Antimicrobial Chemotherapy, 2011; 66(5): 1127-39
[PMID: 21393126, DOI:10.1093/jac/dkr034]

4.Furusyo N, Walaa AH, Eiraku K, Toyoda K, Ogawa E, Ikezaki H, Ihara T, Hayashi T, Hayashi J.
Treatment for eradication of Helicobacter pylori infection among chronic hepatitis C patients.
Gut and Liver, 2011; 5(4): 447-53
[PMID: 22195242, DOI:10.5009/gnl.2011.5.4.447]

5.Ogawa E, Furusyo N, Murata M, Ohnishi H, Toyoda K, Taniai H, Ihara T, Ikezaki H, Hayashi T, Kainuma M, Hayashi J.
Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog.
Hepatology Research, 2011; 41(12): 1178-88
[PMID: 21917085, DOI:10.1111/j.1872-034X.2011.00869.x]

6.Furusyo N, Ogawa E, Sudoh M, Murata M, Ihara T, Hayashi T, Ikezaki H, Hiramine S, Mukae H, Toyoda K, Taniai H, Okada K, Kainuma M, Kajiwara E, Hayashi J.
Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial.
Journal of Hepatology, 2012; 57(6): 1186-92
[PMID: 22889955, DOI:10.1016/j.jhep.2012.08.003]

7.Ogawa E, Furusyo N, Murata M, Ikezaki H, Ihara T, Hayashi T, Toyoda K, Taniai H, Okada K, Kainuma M, Hayashi J.
Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon α-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1.
Journal of Hepatology, 2012; 57(3): 534-40
[PMID: 22613000, DOI:10.1016/j.jhep.2012.04.027]

8.Toyoda K, Furusyo N, Ihara T, Ikezaki H, Urita Y, Hayashi J.
Serum pepsinogen and Helicobacter pylori infection – a Japanese population study.
European Journal of Clinical Microbiology and Infectious Diseases, 2012; 31(9): 2117-24
[PMID: 22354521, DOI:10.1007/s10096-011-1543-0]

9.Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J.
Plasma glycated albumin level and atherosclerosis: results from the Kyushu and Okinawa Population Study (KOPS).
International Journal of Cardiology, 2013; 167(5): 2066-72
[PMID: 22658569, DOI:10.1016/j.ijcard.2012.05.045]

10.Furusyo N, Ai M, Okazaki M, Ikezaki H, Ihara T, Hayashi T, Hiramine S, Ura K, Kohzuma T, Schaefer EJ, Hayashi J.
Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
Atherosclerosis, 2013; 231(2): 238-45
[PMID: 24267234, DOI:10.1016/j.atherosclerosis.2013.09.008]

11.Furusyo N, Ihara T, Hayashi T, Ikezaki H, Toyoda K, Ogawa E, Okada K, Kainuma M, Murata M, Hayashi J.
The serum undercarboxylated osteocalcin level and the diet of a Japanese population: results from the Kyushu and Okinawa Population Study (KOPS).
Endocrine, 2013; 43(3): 635-42
[PMID: 23001602, DOI:10.1007/s12020-012-9803-z]

12.Okada K, Furusyo N, Ogawa E, Ikezaki H, Ihara T, Hayashi T, Kainuma M, Murata M, Hayashi J.
Association between chronic hepatitis C virus infection and high levels of circulating N-terminal pro brain natriuretic peptide.
Endocrine, 2013; 43(1): 200-5
[PMID: 22581254, DOI:10.1007/s12020-012-9688-x]

13.Ogawa E, Furusyo N, Murata M, Ikezaki H, Ihara T, Hayashi T, Toyoda K, Okada K, Kainuma M, Kajiwara E, Takahashi K, Satoh T, Hayashi J.
Valuable antiviral therapeutic options for the treatment of thrombocytopenia of patients with chronic hepatitis C.
Journal of Viral Hepatitis, 2013; 20(12): 838-46
[PMID: 24304453, DOI:10.1111/jvh.12109]

14.Kainuma M, Furusyo N, Murata M, Ihara T, Ikezaki H, Toyoda K, Okada K, Hayashi J.
The effectiveness of traditional Japanese medicine (Kanpo) in combination with pegylated interferon α plus ribavirin for patients with chronic hepatitis C: A pilot study.
Journal of Traditional Medicine, 2013; 30(3): 132-9
[DOI:10.11339/jtm.30.132]

15. Ikezaki H, Furusyo N, Okada K, Ihara T, Hayashi T, Ogawa E, Kainuma M, Murata M, Hayashi J.
The utility of urinary myo-inositol as a marker of glucose intolerance.
Diabetes Research and Clinical Practice, 2014; 103(1): 88-96
[PMID: 24377833, DOI:10.1016/j.diabres.2013.11.018]

16. Ikezaki H, Furusyo N, Ogawa E, Shimizu M, Hiramine S, Ura K, Mitsumoto F, Takayama K, Toyoda K, Murata M, Hayashi J.
Efficacy and Tolerance of Interferon β Plus Ribavirin Treatment for Chronic Hepatitis C Patients with Depression or Thrombocytopenia Comparison with Pegylated Interferon α Plus Ribavirin Treatment.
Journal of Liver, 2014; 3(3): 155
[DOI:10.4172/2167-0889.1000155]

17.Murata M, Furusyo N, Ogawa E, Mitsumoto F, Hiramine S, Ikezaki H, Takayama K, Shimizu M, Toyoda K, Kainuma M, Hayashi J.
A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patients with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.
Journal of Infection and Chemotherapy, 2014; 20(5): 320-4
[PMID: 24477330, DOI:10.1016/j.jiac.2013.11.006]

18. Mitsumoto F, Murata M, Kato Y, Ura K, Takayama K, Hiramine S, Ikezaki H, Shimizu M, Toyoda K, Ogawa E, Aishima S, Furusyo N, Hayashi J.
Hepatitis B virus-related immune reconstitution inflammatory syndrome in two patients coinfected with human immunodeficiency virus diagnosed with liver biopsy.
Internal Medicine, 2014; 53(18): 2165-70
[PMID: 25224208, DOI:10.2169/internalmedicine.53.2503]

19. Ikezaki H, Furusyo N, Ihara T, Hayashi T, Ura K, Hiramine S, Mitsumoto F, Takayama K, Murata M, Kohzuma T, Ai M, Schaefer EJ, Hayashi J.
Glycated Albumin as a diagnostic tool for diabetes in a general Japanese population.
Metabolism, 2015; 64(6): 698-705
[PMID: 25817605, DOI:10.1016/j.metabol.2015.03.003]

20. Shimizu M, Furusyo N, Mitsumoto F, Takayama K, Ura K, Hiramine S, Ikezaki H, Ihara T, Mukae H, Ogawa E, Toyoda K, Kainuma M, Murata M, Hayashi J.
Subclinical carotid atherosclerosis and triglycerides predict the incidence of chronic kidney disease in the Japanese general population: Results from the Kyushu and Okinawa Population Study (KOPS).
Atherosclerosis, 2015; 238(2): 207-12
[PMID: 25528429, DOI:10.1016/j.atherosclerosis.2014.12.013]

21. Shimizu M, Furusyo N, Ikezaki H, Ogawa E, Hayashi T, Ihara T, Harada Y, Toyoda K, Murata M, Hayashi J.
Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B.
World Journal of Gastroenterology, 2015; 21(7): 2116-23
[PMID: 25717246, DOI:10.3748/wjg.v21.i7.2116]

22. Takayama K, Furusyo N, Ogawa E, Ikezaki H, Shimizu M, Murata M, Hayashi J.
Direct acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patients.
World Journal of Gastroenterology, 2015; 21(15): 4696-706
[PMID: 25914481, DOI:10.3748/wjg.v21.i15.4696]

23. Ikezaki H, Furusyo N, Hiramine S, Ura K, Mitsumoto-Kaseida F, Takayama K, Shimizu M, Toyoda K, Ogawa E, Kainuma M, Murata M, Hayashi J.
Association of IL28B rs8099917 genotype and female sex with spontaneous clearance of hepatitis C virus infection: a Japanese cross-sectional study.
Archives of Virology, 2016; 161(3): 641-48
[PMID: 26660164, DOI:10.1007/s00705-015-2703-9]

24. Ikezaki H, Nomura H, Furusyo N, Ogawa E, Kajiwara E, Takahashi K, Kawano A, Maruyama T, Tanabe Y, Satoh T, Nakamuta M, Kotoh K, Azuma K, Dohmen K, Shimoda S, Hayashi J; The Kyushu University Liver Disease Study (KULDS) Group.
Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular.
Hepatology Research, 2016; 46(3): E174-80
[PMID: 26189962, DOI:10.1111/hepr.12555]

25. Ikezaki H, Ai M, Schaefer EJ, Otokozawa S, Asztalos BF, Nakajima K, Yanhua Z, Liu CT, Jacques PF, Cupples LA, Furusyo N.
Ethnic Differences in Glucose Homeostasis Markers between the Kyushu-Okinawa Population Study and the Framingham Offspring Study.
Scientific Reports, 2016; 6: 36725
[PMID: 27830830, DOI:10.1038/srep36725]

26. Shimizu M, Furusyo N, Tanaka Y, Kato Y, Mitsumoto-Kaseida F, Takayama K, Ura K, Hiramine S, Hayashi T, Ikezaki H, Ihara T, Mukae H, Ogawa E, Toyoda K, Kainuma M, Murata M, Hayashi J.
The relation of postprandial plasma glucose and serum endostatin to the urinary albumin excretion of residents with prediabetes: results from the Kyushu and Okinawa Population Study (KOPS).
International Urology and Nephrology, 2016; 48(6): 851-7
[PMID: 26984739, DOI:10.1007/s11255-016-1258-3]

27. Ikezaki H, Ai M, Schaefer EJ, Otokozawa S, Asztalos BF, Nakajima K, Zhou Y, Liu CT, Jacques PF, Cupples LA, Furusyo N.
Cardiovascular Disease Prevalence and Insulin Resistance in the Kyushu-Okinawa Population Study and the Framingham Offspring Study.
Journal of Clinical Lipidology, 2017; 11(2): 348-56
[PMID: 28502490, DOI:10.1016/j.jacl.2017.01.014]

28. Ikezaki H, Furusyo N, Jacques PF, Shimizu M, Murata M, Schaefer EJ, Urita Y, Hayashi J.
Higher dietary cholesterol and omega-3 fatty acid intakes are associated with a lower success rate of Helicobacter pylori eradication therapy in Japan.
The American Journal of Clinical Nutrition, 2017; 106(2): 581-8
[PMID: 28659302, DOI:10.3945/ajcn.116.144873]

29. Koyama T, Kuriyama N, Ozaki E, Matsui D, Watanabe I, Takeshita W, Iwai K, Watanabe Y, Nakatochi M, Shimanoe C, Tanaka K, Oze I, Ito H, Uemura H, Katsuura-Kamano S, Ibusuki R, Shimoshikiryo I, Takashima N, Kadota A, Kawai S, Sasakabe T, Okada R, Hishida A, Naito M, Kuriki K, Endoh K, Furusyo N, Ikezaki H, Suzuki S, Hosono A, Mikami H, Nakamura Y, Kubo M, Wakai K.
Genetic Variants of RAMP2 and CLR are Associated with Stroke.
Journal of Atherosclerosis and Thrombosis, 2017; 24(12): 1267-81
[PMID: 28904253, DOI:10.5551/jat.41517]

30. Nakagawa-Senda H, Hachiya T, Shimizu A, Hosono S, Oze I, Watanabe M, Matsuo K, Ito H, Hara M, Nishida Y, Endoh K, Kuriki K, Katsuura-Komano S, Arisawa K, Nindita Y, Ibusuki R, Suzuki S, Hosono A, Mikami H, Nakamura Y, Takashima N, Nakamura Y, Kuriyama N, Ozaki E, Furusyo N, Ikezaki H, Nakatochi M, Sasakabe T, Kawai S, Okada R, Hishida A, Naito M, Wakai K, Momozawa Y, Kubo M, Tanaka H.
A genome-wide association study in the Japanese population identifies the 12q24 locus for habitual coffee consumption: The J-MICC Study.
Scientific Reports, 2018; 8(1): 1493
[PMID: 29367735, DOI:10.1038/s41598-018-19914-w]

31. Hishida A, Nakatochi M, Akiyama M, Kamatani Y, Nishiyama T, Ito H, Oze I, Nishida Y, Hara M, Takashima N, Turin TC, Watanabe M, Suzuki S, Ibusuki R, Shimoshikiryo I, Nakamura Y, Mikami H, Ikezaki H, Furusyo N, Kuriki K, Endoh K, Koyama T, Matsui D, Uemura H, Arisawa K, Sasakabe T, Okada R, Kawai S, Naito M, Momozawa Y, Kubo M, Wakai K. The Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group.
Genome-wide association study of renal function traits with 1000 Genomes-based imputation in a large population-based Japanese cohort – data from the J-MICC Study.
American Journal of Nephrology, 2018; 47(5): 304-16
[PMID: 29779033, DOI: 10.1159/000488946]

32. Tanaka Y, Furusyo N, Kato Y, Ueyama T, Yamasaki S, Ikezaki H, Murata M, Hayashi J.
Correlation between thyroid stimulating hormone and renal function in euthyroid residents of Japan: results from the Kyushu and Okinawa Population Study (KOPS).
Journal of Atherosclerosis and Thrombosis, 2018; 25(4): 335-43
[PMID: 29046502, DOI: 10.5551/jat.41251]

33. Kato Y, Furusyo N, Tanaka Y, Yamasaki S, Ueyama T, Takayama K, Mitsumoto-Kaseida F, Murata M, Ikezaki H, Hayashi J.
Association of the serum endostatin level, renal function, and carotid atherosclerosis of healthy residents of Japan: Results from the Kyushu and Okinawa Population Study (KOPS).
Journal of Atherosclerosis and Thrombosis, 2018; 25(9): 829-35
[PMID: 29398676, DOI: 10.5551/jat.42234]

34. Ito Y, Ohta M, Ikezaki H, Hirano Y, Machida A, Schaefer EJ, Furusyo N.
Development and population results of a fully automated homogeneous assay for LDL triglycerides.
Journal of Applied Laboratory Medicine, 2018; 2(5): 746-56
[DOI: 10.1373/jalm.2017.024554]

35. Hara M, Hachiya T, Sutoh Y, Matsuo K, Nishida Y, Shimanoe C, Tanaka K, Shimizu A, Ohnaka K, Kawaguchi T, Oze I, Matsuda F, Ito H, Kawai S, Hishida A, Okada R, Sasakabe T, Hirata A, Ibusuki R, Nindita Y, Furusyo N, Ikezaki H, Kuriyama N, Ozaki E, Mikami H, Nakamura Y, Suzuki S, Hosono A, Katsuura-Kamano S, Arisawa K, Kuriki K, Endoh K, Takashima N, Kadota A, Nakatochi M, Momozawa Y, Kubo M, Naito M, Wakai K.
Genome-wide association study of leisure-time exercise behavior in Japanese adults.
Medicine&Science in Sports&Exercise, 2018; 50(12): 2433-41
[PMID: 30102679, DOI: 10.1249/MSS. 0000000000001712]

36. Tamura T, Kadomatsu Y, Tsukamoto M, Okada R, Sasakabe T, Kawai S, Hishida A, Hara M, Tanaka K, Shimoshikiryo I, Takezaki T, Watanabe I, Matsui D, Nishiyama T, Suzuki S, Endoh K, Kuriki K, Kita Y, Katsuura-Kamano S, Arisawa K, Ikezaki H, Furusyo N, Koyanagi NY, Oze I, Nakamura Y, Mikami H, Naito M, Wakai K; for the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study.
Association of exposure level to passive smoking with hypertension among lifetime nonsmokers in Japan: a cross-sectional study.
Medicine (Baltimore), 2018; 97(48): e13241
[PMID: 30508907, DOI: 10.1097/MD.0000000000013241]

37. Ikezaki H, Fisher VA, Lim E, Ai M, Liu CT, Cupples LA, Nakajima K, Asztalos BF, Furusyo N, Schaefer EJ.
Direct versus calculated low-density lipoprotein cholesterol and C reactive protein in cardiovascular disease risk assessment in the Framingham Offspring Study.
Clinical Chemistry, 2019; 65(9): 1102-14
[PMID: 31239251, DOI; 10.1373/clinchem.2019.304600]

38. Kainuma M, Furusyo N, Urita Y, Ikezaki H, Ura K, Nakaguchi T, Namiki T.
Objective tongue color and gastroesophageal reflux disease: Cross-sectional study.
Traditional&Kampo Medicine, 2019; 6(1): 19-25
[DOI: 10.1002/tkm2.1210]

39. Iwasaki Y, Arisawa K, Katsuura-Kamano S, Uemura H, Tsukamoto M, Kadomatsu Y, Okada R, Hishida A, Tanaka K, Hara M, Takezaki T, Shimatani K, Ozaki E, Koyama T, Suzuki S, Nakagawa-Senda H, Kuriki K, Miyagawa N, Kadota A, Ikezaki H, Furusyo N, Oze I, Ito H, Mikami H, Nakamura Y, Wakai K.
Associations of Nutrient Patterns with the Prevalence of Metabolic Syndrome: Results from the Baseline Data of the Japan Multi-Institutional Collaborative Cohort Study.
Nutrients, 2019; 11(5): 990
[PMID: 31052301, DOI: 10.3390/nu11050990]

40. Uemura H, Katsuura-Kamano S, Iwasaki Y, Arisawa K, Hishida A, Okada R, Tamura T, Kubo Y, Ito H, Oze I, Shimanoe C, Nishida Y, Nakamura Y, Takashima N, Suzuki S, Nakagawa-Senda H, Nishimoto D, Takezaki T, Mikami H, Nakamura Y, Furusyo N, Ikezaki H, Ozaki E, Koyama T, Kuriki K, Endoh K, Naito M, Wakai K; Japan Multi-institutional Collaborative Cohort (J-MICC) Study Group.
Independent relationships of daily life activity and leisure-time exercise with metabolic syndrome and its traits in the general Japanese population.
Endocrine, 2019; 64(3): 552-63
[PMID: 31011988, DOI: 10.1007/s12020-019-01926-9]

41. Nakatochi M, Kanai M, Nakayama A, Hishida A, Kawamura Y, Ichihara S, Akiyama M, Ikezaki H, Furusyo N, Shimizu S, Yamamoto K, Hirata M, Okada R, Kawai S, Kawaguchi M, Nishida Y, Shimanoe C, Ibusuki R, Takezaki T, Nakajima M, Takao M, Ozaki E, Matsui D, Nishiyama T, Suzuki S, Takashima N, Kita Y, Endoh K, Kuriki K, Uemura H, Arisawa K, Oze I, Matsuo K, Nakamura Y, Mikami H, Tamura T, Nakashima H, Nakamura T, Kato N, Matsuda K, Murakami Y, Matsubara T, Naito M, Kubo M, Kamatani Y, Shinomiya N, Yokota M, Wakai K, Okada Y, Matsuo H.
Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals.
Communications Biology, 2019; 2: 115
[PMID: 30993211, DOI: 10.1038/s42003-019-0339-0]

42. Nakayama A, Nakatochi M, Kawamura Y, Yamamoto K, Nakaoka H, Shimizu S, Higashino T, Koyama T, Hishida A, Kuriki K, Watanabe M, Shimizu T, Ooyama K, Ooyama H, Nagase M, Hidaka Y, Matsui D, Tamura T, Nishiyama T, Shimanoe C, Katsuura-Kamano S, Takashima N, Shirai Y, Kawaguchi M, Takao M, Sugiyama R, Takada Y, Nakamura T, Nakashima H, Tsunoda M, Danjoh I, Hozawa A, Hosomichi K, Toyoda Y, Kubota Y, Takada T, Suzuki H, Stiburkova B, Major TJ, Merriman TR, Kuriyama N, Mikami H, Takezaki T, Matsuo K, Suzuki S, Hosoya T, Kamatani Y, Kubo M, Ichida K, Wakai K, Inoue I, Okada Y, Shinomiya N, Matsuo H, Japan Gout Genomics Consortium (Japan Gout). (Listed as one of collaborators in Japan Gout)
Subtype-specific gout susceptibility loci and enrichment of selection pressure on ABCG2 and ALDH2 identified by subtype genome-wide meta-analyses of clinically defined gout patients.
Annals of the Rheumatic Diseases, 2020; 79(5): 657-665
[PMID: 32238385, DOI: 10.1136/annrheumdis-2019-216644]

43. Okada R, Kadomatsu Y, Tsukamoto M, Sasakabe T, Kawai S, Tamura T, Hishida A, Ikezaki H, Furusyo N, Tanaka K, Hara M, Suzuki S, Watanabe M, Takezaki T, Nishimoto D, Matsui D, Watanabe I, Kuriki K, Takashima N, Nakamura Y, Kamano S, Arisawa K, Mikami H, Nakamura Y, Oze I, Koyanagi Y, Naito M, Wakai K.
Combined effect of weight gain within normal weight range and parental hypertension on the prevalence of hypertension; from the J-MICC Study.
Journal of Human Hypertension, 2020; 34(2): 125-31
[PMID: 31481698, DOI: 10.1038/s41371-019-0230-y]

44. Nishida Y, Hachiya T, Hara M, Shimanoe C, Tanaka K, Sutoh Y, Shimizu A, Hishida A, Tsukamoto M, Kadomatsu Y, Oze I, Koyanagi YN, Kuriyama N, Koyama T, Ibusuki R, Takezaki T, Ikezaki H, Furusyo N, Takashima N, Kadota A, Uemura H, Katsuura-Kamano S, Suzuki S, Nakagawa-Senda H, Kuriki K, Mikami H, Nakamura Y, Momozawa Y, Kubo M, Nakatochi M, Naito M, Wakai K, for the J-MICC Study Group.
The interaction between ABCA1 polymorphism and physical activity on the HDL-cholesterol levels in a Japanese population.
Journal of Lipid Research, 2020; 61(1): 86-94
[PMID: 31694877, DOI: 10.1194/jlr.P091546]

45. Sakai K, Tanikawa C, Hirasawa A, Chiyoda T, Yamagami W, Kataoka F, Susumu N, Terao C, Kamatani Y, Takahashi A, Momozawa Y, Hirata M, Kubo M, Fuse N, Takai-Igarashi T, Shimizu A, Fukushima A, Kadota A, Arisawa K, Ikezaki H, Wakai K, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Aoki D, Matsuda K.
Identification of a novel uterine leiomyoma GWAS locus in a Japanese population.
Scientific Reports, 2020; 10(1): 1197
[PMID: 31988393, DOI: 10.1038/s41598-020-58066-8]

46. Ikezaki H, Furusyo N, Yokota Y, Ai M, Asztalos BF, Murata M, Hayashi J, Schaefer EJ.
Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression.
Journal of Atherosclerosis and Thrombosis, 2020; 27(10): 1108-1122
[PMID: 32281547, DOI: 10.5551/jat.54130]

47. Koyama T, Kuriyama N, Ozaki E, Uehara R, Nishida Y, Shimanoe C, Hishida A, Tamura T, Tsukamoto M, Kadomatsu Y, Oze I, Matsuo K, Mikami H, Nakamura Y, Ibusuki R, Takezaki T, Suzuki S, Nishiyama T, Kuriki K, Takashima N, Kadota A, Uemura H, Katsuura-Kamano S, Ikezaki H, Murata M, Takeuchi K, Wakai K.
Sedentary time is associated with cardiometabolic diseases in a large Japanese population: a cross-sectional study.
Journal of Atherosclerosis and Thrombosis, 2020; 27(10): 1097-1107
[PMID: 32269208, DOI: 10.5551/jat.54320]

48. Iwase M, Matsuo K, Nakatochi M, Oze I, Ito H, Koyanagi Y, Ugai T, Kasugai Y, Hishida A, Takeuchi K, Okada R, Kubo Y, Shimanoe C, Tanaka K, Ikezaki H, Murata M, Takezaki T, Nishimoto D, Kuriyama N, Ozaki E, Suzuki S, Watanabe M, Mikami H, Nakamura Y, Uemura H, Katsuura-Kamano S, Kuriki K, Kita Y, Takashima N, Nagino M, Momozawa Y, Kubo M, Wakai K.
Differential effect of polymorphisms on body mass index across the life course of Japanese: the Japan Multi-Institutional Collaborative Cohort Study.
Journal of Epidemiology, 2021; 31(3): 172-179
[PMID: 32147644, DOI: 10.2188/jea.JE20190296]

49. Matsunaga H, Ito K, Akiyama M, Takahashi A, Koyama S, Nomura S, Ieki H, Ozaki K, Onouchi Y, Sakaue S, Suna S, Ogishima S, Yamamoto M, Hozawa A, Satoh M, Sasaki M, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Tanaka K, Arisawa K, Ikezaki H, Takashima N, Naito M, Wakai K, Sakata Y, Morita H, Sakata Y, Matsuda K, Murakami Y, Akazawa H, Kubo M, Kamatani Y, Komuro I.
Transethnic meta-analysis of genome-wide association studies identifies three new loci and characterizes population-specific differences for coronary artery disease.
Circulation: Genomic and Precision Medicine, 2020; 13(3): e002670
[PMID: 32469254, DOI: 10.1161/CIRCGEN.119.002670]

50. Arisawa K, Katsuura‐Kamano S, Uemura H, Tien NV, Hishida A, Tamura T, Kubo Y, Tsukamoto M, Tanaka K, Hara M, Takezaki T, Nishimoto D, Koyama T, Ozaki E, Suzuki S, Nishiyama T, Kuriki K, Kadota A, Takashima N, Ikezaki H, Murata M, Oze I, Matsuo K, Mikami H, Nakamura Y, Takeuchi K, Wakai K.
Association of Dietary Acid Load with the Prevalence of Metabolic Syndrome among Participants in Baseline Survey of the Japan Multi‐Institutional Collaborative Cohort Study.
Nutrients, 2020; 12(6): E1605
[PMID: 32486113, DOI: 10.3390/nu12061605]

51. Suzuki T, Nakamura Y, Matsuo K, Oze I, Doi Y, Narita A, Shimizu A, Imaeda N, Goto C, Matsui K, Nakatochi M, Miura K, Takashima N, Kuriki K, Shimanoe C, Tanaka K, Ikezaki H, Murata M, Ibusuki R, Takezaki T, Koyanagi Y, Ito H, Matsui D, Koyama T, Mikami H, Nakamura Y, Suzuki S, Nishiyama T, Katsuura-Kamano S, Arisawa K, Takeuchi K, Tamura T, Okada R, Kubo Y, Momozawa Y, Kubo M, Kita Y, Wakai K, for the J-MICC Research Group.
A genome ‐ wide association study on fish consumption in a Japanese population ‐ the Japan Multi ‐ Institutional Collaborative Cohort study ‐ A conventional and a conditional analyses.
European Journal of Clinical Nutrition, 2021; 75(3): 480-488
[PMID: 32895509, DOI: 10.1038/s41430-020-00702-7]

52. Takeuchi K, Naito M, Kawai S, Tsukamoto M, Kadomatsu Y, Kubo Y, Okada R, Nagayoshi M, Tamura T, Hishida A, Nakatochi M, Sasakabe T, Hashimoto S, Eguchi H, Momozawa Y, Ikezaki H, Murata M, Furusyo N, Tanaka K, Hara M, Nishida Y, Matsuo K, Ito H, Oze I, Mikami H, Nakamura Y, Kusakabe M, Takezaki T, Ibusuki R, Shimoshikiryo I, Suzuki S, Nishiyama T, Watanabe M, Koyama T, Ozaki E, Watanabe I, Kuriki K, Kita Y, Ueshima H, Matsui K, Arisawa K, Uemura H, Katsuura-Kamano S, Nakamura S, Narimatsu H, Hamajima N, Tanaka H, Wakai K; for the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study.
Study profile of the Japan Multi-institutional Collaborative Cohort (J-MICC) Study.
Journal of Epidemiology, 2021; 31(12): 660-668
[PMID: 32963210, DOI: 10.2188/jea.JE20200147]

53. Koyama S, Ito K, Terao C, Akiyama M, Horikoshi M, Momozawa Y, Matsunaga H, Ieki H, Ozaki K, Onouchi Y, Takahashi A, Nomura S, Morita H, Akazawa H, Kim C, Seo JS, Higasa K, Iwasaki M, Yamaji T, Sawada N, Tsugane S, Koyama T, Ikezaki H, Takashima N, Tanaka K, Arisawa K, Kuriki K, Naito M, Wakai K, Suna S, Sakata Y, Sato H, Hori M, Sakata Y, Matsuda K, Murakami Y, Aburatani H, Kubo M, Matsuda F, Kamatani Y, Komuro I.
Population-specific and transethnic genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease.
Nature Genetics, 2020; 52(11): 1169-77.
[PMID: 33020668, DOI: 10.1038/s41588-020-0705-3]

54. Hishida A, Nakatochi M, Tamura T, Nagayoshi M, Okada R, Kubo Y, Tsukamoto M, Kadomatsu Y, Suzuki S, Nishiyama T, Kuriyama N, Watanabe I, Takezaki T, Nishimoto D, Kuriki K, Arisawa K, Katsuura-Kamano S, Mikami H, Kusakabe M, Oze I, Koyanagi YN, Nakamura Y, Kadota A, Shimanoe C, Tanaka K, Ikezaki H, Murata M, Kubo M, Momozawa Y, Takeuchi K, Wakai K.
Genome-wide association study of serum PSA levels based on 1000Genomes-imputed data in Japanese: the J-MICC Study.
Nagoya J Med Sci, 2021; 83(1): 183-94.
[PMID: 33727749, DOI: 10.18999/nagjms.83.1.183]

55. Shimoshikiryo I, Ibusuki R, Shimatani K, Nishimoto D, Takezaki T, Nishida Y, Shimanoe C, Hishida A, Tamura T, Okada R, Kubo Y, Ozaki E, Matsui D, Suzuki S, Nakagawa-Senda H, Kuriki K, Kita Y, Takashima N, Arisawa K, Uemura H, Ikezaki H, Furusyo N, Oze I, Koyanagi YN, Mikami H, Nakamura Y, Naito M, Wakai K, for the J-MICC Study Group.
Association between alcohol intake pattern and metabolic syndrome components and simulated change by alcohol intake reduction: A cross-sectional study from the Japan Multi-Institutional Collaborative Cohort Study.
Alcohol, 2020; 89: 129-38.
[PMID: 32991979, DOI: 10.1016/j.alcohol.2020.09.002]

56. Tamura T, Kuriyama N, Koyama T, Ozaki E, Matsui D, Kadomatsu Y, Tsukamoto M, Kubo Y, Okada R, Hishida A, Sasakabe T, Kawai S, Naito M, Takashima N, Kadota A, Tanaka K, Hara M, Suzuki S, Nakagawa-Senda H, Takezaki T, Shimoshikiryo I, Ikezaki H, Murata M, Oze I, Ito H, Mikami H, Nakamura Y, Kuriki K, Arisawa K, Uemura H, Takeuchi K, Wakai K.
Association between plasma levels of homocysteine, folate, and vitamin B12, and dietary folate intake and hypertension in a cross-sectional study.
Scientific Reports, 2020; 10(1): 18499.
[PMID: 33116160, DOI: 10.1038/s41598-020-75267-3]

57. Suzuki H, Nakamura Y, Matsuo K, Imaeda N, Goto C, Narita A, Shimizu A, Takashima N, Matsui K, Miura K, Nakatochi M, Hishida A, Tamura T, Kadomatsu Y, Okada R, Nishida Y, Shimano C, Nishimoto D, Takezaki T, Oze I, Ito H, Ikezaki H, Murata M, Matsui D, Ozaki E, Mikami H, Nakamura Y, Suzuki S, Watanabe M, Arisawa K, Uemura H, Kuriki K, Momozawa Y, Kubo M, Kita Y, Takeuchi K, Wakai K for the J-MICC Research Group.
A genome-wide association study in Japanese identified one variant associated with a preference for a Japanese dietary pattern.
European Journal of Clinical Nutrition, 2021; 75(6): 937-945
[PMID: 33281188, DOI: 10.1038/s41430-020-00823-z]

58. Ikezaki H, Lim E, Cupples LA, Liu CT, Asztalos BF, Schaefer EJ.
Small dense low-density lipoprotein cholesterol is the most atherogenic lipoprotein parameter in the prospective Framingham Offspring Study.
JAHA: Journal of the American Heart Association, 2021; 10(5): e019140.
[PMID: 33586462, DOI: 10.1161/JAHA.120.019140]

59. Usui Y, Matsuo K, Oze I, Ugai T, Koyanagi Y, Maeda Y, Ito H, Hishida A, Takeuchi K, Tamura T, Tsukamoto M, Kadomatsu Y, Hara M, Nishida Y, Shimoshikiryo I, Takezaki T, Ozaki E, Matsui D, Watanabe I, Suzuki S, Watanabe M, Nakagawa-Senda H, Mikami H, Nakamura Y, Arisawa K, Uemura H, Kuriki K, Takashima N, Kadota A, Ikezaki H, Murata M, Nakatochi M, Momozawa Y, Kubo M, Wakai K.
Impact of PSCA polymorphisms on the risk of duodenal ulcer.
Journal of Epidemiology, 2021; 31(1): 12-20.
[PMID: 31839644, DOI: 10.2188/jea.JE20190184]

60. Suzuki S, Goto A, Nakatochi M, Narita A, Yamaji T, Sawada N, Katagiri R, Iwagami M, Hanyuda A, Hachiya T, Sutoh Y, Oze I, Koyanagi Y, Kasugai Y, Taniyama Y, Ito H, Ikezaki H, Nishida Y, Tamura T, Mikami H, Takezaki T, Suzuki S, Ozaki E, Kuriki K, Takashima N, Arisawa K, Takeuchi K, Tanno K, Shimizu A, Tamiya G, Hozawa A, Kinoshita K, Wakai K, Sasaki M, Yamamoto M, Matsuo K, Tsugane S, Iwasaki M.
Body mass index and colorectal cancer risk: a Mendelian randomization study.
Cancer Science, 2021; 112(4): 1579-88.
[PMID: 33506574, DOI: 10.1111/cas.14824]

61. Fujii R, Hishida A, Nishiyama T, Nakatochi M, Matsuo K, Ito H, Nishida Y, Shimanoe C, Nakamura Y, Turin TC, Suzuki S, Watanabe M, Ibusuki R, Takezaki T, Mikami H, Nakamura Y, Ikezaki H, Murata M, Kuriki K, Kuriyama N, Matsui D, Arisawa K, Katsuura-Kamano S, Tsukamoto M, Tamura T, Kubo Y, Kondo T, Momozawa Y, Kubo M, Takeuchi K, Wakai K for the J-MICC Study Group.
Assessing the relationship between high-sensitivity C-reactive protein and kidney function employing mendelian randomization in a Japanese community based J-MICC Study.
Journal of Epidemiology, 2022; 32(11): 483-8.
[PMID: 33612706, DOI: 10.2188/jea.JE20200540]

62. Suzuki T, Nakamura Y, Doi Y, Narita A, Shimizu A, Imaeda N, Goto C, Matsui K, Kadota A, Miura K, Nakatochi M, Tanaka K, Hara M, Ikezaki H, Murata M, Takezaki T, Nishimoto D, Matsuo K, Oze I, Kuriyama N, Ozaki E, Mikami H, Nakamura Y, Watanabe M, Suzuki S, Katsuura-Kamano S, Arisawa K, Kuriki K, Momozawa Y, Kubo M, Takeuchi K, Kita Y, Wakai K, for the J-MICC Research Group.
A Genome-wide Association Study on Confection Consumption in a Japanese 1 Population- The Japan Multi-Institutional Collaborative Cohort study.
British Journal of Nutrition, 2021; 126(12): 1843-1851.
[PMID: 33632354, DOI: 10.1017/S0007114521000684]

63. Imaeda N, Goto C, Sasakabe T, Mikami H, Oze I, Hosono A, Naito M, Miyagawa N, Ozaki E, Ikezaki H, Nanri H, Nakahata TN, Kamano SK, Kuriki K, Yaguchi YT, Kayama T, Kurihara A, Harada S, Wakai K.
Reproducibility and validity of food group intake in a short food frequency questionnaire for the middle-aged Japanese population.
Environmental Health and Preventive Medicine, 2021; 26(1): 28.
[PMID: 33653279, DOI: 10.1186/s12199-021-00951-3]

64. Otonari J, Ikezaki H, Furusyo N, Sudo N.
Do neuroticism and extraversion personality traits influence disease-specific risk factors for mortality from cancer and cardiovascular disease in a Japanese population?
Journal of Psychosomatic Research, 2021; 144: 110422
[PMID: 33756148, DOI: 10.1016/j.jpsychores.2021.110422]

65. Koyama T, Ozaki E, Kuriyama N, Tomida S, Yoshida T, Uehara R, Tanaka K, Hara M, Hishida A, Okada R, Kubo Y, Oze I, Koyanagi Y, Mikami H, Nakamura Y, Shimoshikiryo I, Takezaki T, Suzuki S, Otani T, Kuriki K, Takashima N, Kadota A, Arisawa K, Katsuura-Kamano S, Ikezaki H, Murata M, Takeuchi K, Wakai K, for the Japan Multi-institutional Collaborative Cohort (J-MICC) Study Group.
Effect of Underlying Cardiometabolic Diseases on the Association Between Sedentary Time and All-cause Mortality in a Large Japanese Population: A Cohort Analysis Based on the J-MICC Study.
JAHA: Journal of the American Heart Association, 2021; 10(13): e018293.
[PMID: 34121417, DOI: 10.1161/JAHA.120.018293]

66. Otonari J, Ikezaki H, Furusyo N, Sudo N.
Association of lifestyle factors with osteoporosis and fracture in postmenopausal women: a Japanese cohort study.
Menopause, 2021; 28(11): 1254-63.
[PMID: 34313618, DOI: 10.1097/GME.0000000000001840]

67. Nakamura Y, Narita A, Sutoh Y, Imaeda N, Goto C, Matsui K, Takashima N, Kadota A, Miura K, Nakatochi M, Tamura T, Hishida A, Nakashima R, Ikezaki H, Hara M, Nishida Y, Takezaki T, Ibusuki R, Oze I, Ito H, Kuriyama N, Ozaki E, Mikami H, Kusakabe M, Nakagawa-Senda H, Suzuki S, Katsuura-Kamano S, Arisawa K, Kuriki K, Momozawa Y, Kubo M, Takeuchi K, Kita Y, Wakai K.
A genome-wide association study on meat consumption in a Japanese population: the Japan Multi-Institutional Collaborative Cohort study.
Journal of Nutrition Science, 2021; 10: e61.
[PMID: 34733494, DOI: 10.1017/jns.2021.49]

68. Nindita Y, Nakatochi M, Ibusuki R, Shimoshikiryo I, Nishimoto D, Shimatani K, Takezaki T, Ikezaki H, Murata M, Hara M, Nishida Y, Tamura T, Hishida A, Nagayoshi M, Okada R, Matsuo K, Ito H, Mikami H, Nakamura Y, Otani T, Suzuki S, Koyama T, Ozaki E, Kuriki K, Takashima N, Miyagawa N, Arisawa K, Katsuura-Kamao S, Momozawa Y, Kubo M, Takeuchi K, Wakai K.
Population-Based Impact of Smoking, Drinking, and Genetic Factors on HDL-Cholesterol Levels in J-MICC Study Participants.
Journal of Epidemiology, 2023; 33(4): 193-200.
[PMID: 34421081, DOI: 10.2188/jea.JE20210142]

69. Nagayoshi M, Takeuchi K, Tamada Y, Yasufumi K, Kubo Y, Okada R, Tamura T, Hishida A, Otonari J, Ikezaki H, Nishida Y, Shimanoe C, Koyanagi YN, Matsuo K, Haruo M, Miho K, Nishimoto D, Shibuya K, Suzuki S, Nishiyama T, Ozaki E, Watanabe I, Kuriki K, Takashima N, Kadota A, Arisawa K, Katsuura-Kamano S, Wakai K.
Sex-specific Relationship between Stress Coping Strategies and All-Cause Mortality: Japan Multi-Institutional Collaborative Cohort Study.
Journal of Epidemiology, 2023; 33(5): 236-45.
[PMID: 34565763, DOI: 10.2188/jea.JE20210220]

70. Hara M, Nishida Y, Tanaka K, Shimanoe C, Koga K, Furukawa T, Higaki Y, Shinchi K, Ikezaki H, Murata M, Takeuchi K, Tamura T, Hishida A, Tsukamoto M, Kadomatsu Y, Matsuo K, Oze I, Haruo M, Miho K, Takezaki T, Ibusuki R, Suzuki S, Nakagawa-Senda H, Matsui D, Koyama T, Kuriki K, Takashima N, Nakamura Y, Arisawa K, Katsuura-Kamano S, Wakai K.
Moderate-to-vigorous physical activity and sedentary behavior are independently associated with renal function: a cross-sectional study.
Journal of Epidemiology, 2023; 33(6): 285-93.
[PMID: 34657911, DOI: 10.2188/jea.JE20210155]

71. Ikezaki H, Nakashima R, Hara Y, Hayashi J, Hara H, Nomura H, Shimono N.
Low immune response in the elderly Japanese population after fully BNT162b2 vaccination.
Journal of Hospital General Medicine 2022; 4(1): 25-8.

72. Ikezaki H, Furusyo N, Nakashima R, Umemoto M, Yamamoto K, Matsumoto Y, Ohta A, Yamasaki S, Hiramine S, Takayama K, Ogawa E, Toyoda K, Murata M, Shimono N, Hayashi J.
Cohort profile: the Kyushu and Okinawa Population Study (KOPS) – a large prospective cohort study in Japan.
BMJ Open 2021; 11(12): e053763.
[PMID: 34933862, DOI: 10.1136/bmjopen-2021-053763]

73. Katsuura-Kamano S, Arisawa K, Uemura H, Van Nguyen T, Takezaki T, Ibusuki R, Suzuki S, Otani T, Okada R, Kubo Y, Tamura T, Hishida A, Koyama T, Matsui D, Kuriki K, Takashima N, Miyagawa N, Ikezaki H, Matsumoto Y, Nishida Y, Shimanoe C, Oze I, Matsuo K, Mikami H, Kusakabe M, Takeuchi K, Wakai K; Japan Multi-Institutional Collaborative Cohort J-MICC Study.
Association of skipping breakfast and short sleep duration with the prevalence of metabolic syndrome in the general Japanese population: Baseline data from the Japan Multi-Institutional Collaborative cohort study.
Preventive Medicine Reports 2021; 24: 101613.
[PMID: 34976669, DOI: 10.1016/j.pmedr.2021.101613]

74. Furukawa T, Nishida Y, Hara M, Shimanoe C, Koga K, Iwasaka C, Higaki Y, Tanaka K, Nakashima R, Ikezaki H, Hishida A, Tamura T, Kato Y, Tamada Y, Matsuo K, Ito H, Mikami H, Kusakabe M, Ibusuki R, Shibuya K, Suzuki S, Nakagawa-Senda H, Ozaki E, Matsui D, Kuriki K, Nakamura Y, Kadota A, Arisawa K, Katsuura-Kamano S, Takeuchi K, Wakai K; Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group.
Effect of the interaction between physical activity and estimated macronutrient intake on HbA1c: population-based cross-sectional and longitudinal studies.
BMJ Open Diabetes Research & Care 2022; 10(1): e002479.
[PMID: 34980592, DOI: 10.1136/bmjdrc-2021-002479]

75. Koga K, Hara M, Shimanoe C, Nishida Y, Furukawa T, Iwasaka C, Tanaka K, Otonari J, Ikezaki H, Kubo Y, Kato Y, Tamura T, Hishida A, Matsuo K, Ito H, Nakamura Y, Kusakabe M, Nishimoto D, Shibuya K, Suzuki S, Watanabe M, Ozaki E, Matsui D, Kuriki K, Takashima N, Kadota A, Arisawa K, Katsuura-Kamano S, Takeuchi K, Wakai K.
Association of perceived stress and coping strategies with the renal function in middle-aged and older Japanese men and women.
Scientific Reports 2022; 12(1): 291.
[PMID: 34997128, DOI: 10.1038/s41598-021-04324-2]

76. Ohashi M, Miura K, Takashima N, Kadota A, Saito Y, Tsuji S, Murakami T, Kadomatsu Y, Nagayoshi M, Hara M, Tanaka K, Tamura T, Hishida A, Takezaki T, Shimoshikiryo I, Ozaki E, Watanabe I, Suzuki S, Watanabe M, Kuriki K, Arisawa K, Katsuura-Kamano S, Yamasaki S, Ikezaki H, Oze I, Koyanagi YN, Mikami H, Nakamura Y, Takeuchi K, Kita Y, Wakai K; Japan Multi-institutional Collaborative Cohort (J-MICC) Study Group.
The association of reproductive history with hypertension and obesity according to menopausal status: the J-MICC Study.
Hypertension Research 2022; 45(4): 708-14.
[PMID: 35031776, DOI: 10.1038/s41440-021-00820-0]

77. Matsunaga T, Kadomatsu Y, Tsukamoto M, Kubo Y, Okada R, Nagayoshi M, Tamura T, Hishida A, Takezaki T, Shimoshikiryo I, Suzuki S, Nakagawa H, Takashima N, Saito Y, Kuriki K, Arisawa K, Katsuura-Kamano S, Kuriyama N, Matsui D, Mikami H, Nakamura Y, Oze I, Ito H, Murata M, Ikezaki H, Nishida Y, Shimanoe C, Takeuchi K, Wakai K.
Associations of breastfeeding history with metabolic syndrome and cardiovascular risk factors in community-dwelling parous women: The Japan Multi-Institutional Collaborative Cohort Study.
PLoS One 2022; 17(1): e0262252.
[PMID: 35045125, DOI: 10.1371/journal.pone.0262252]

78. Fujii R, Hishida A, Nakatochi M, Tsuboi Y, Suzuki K, Kondo T, Ikezaki H, Hara M, Okada R, Tamura T, Shimoshikiryo I, Suzuki S, Koyama T, Kuriki K, Takashima N, Arisawa K, Momozawa Y, Kubo M, Takeuchi K, Wakai K, for the J-MICC Study Group.
Associations of genome-wide polygenic risk score and risk factors with hypertension in a Japanese population.
Circulation: Genomic and Precision Medicine 2022; 15(4): e003612.
[PMID: 35666837, DOI: 10.1161/CIRCGEN.121.003612]

79. Ikezaki H, Nomura H, Shimono N.
Dynamics of anti-Spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workers.
Journal of Infection and Chemotherapy 2022; 28(6): 802-5.
[PMID: 35288023, PMCID: PMC8901382, DOI: 10.1016/j.jiac.2022.02.024]

80. Nguyen TV, Arisawa K, Katsuura-Kamano S, Ishizu M, Nagayoshi M, Okada R, Hishida A, Tamura T, Hara M, Tanaka K, Nishimoto D, Shibuya K, Koyama T, Watanabe I, Suzuki S, Nishiyama T, Kuriki K, Nakamura Y, Saito Y, Ikezaki H, Otonari J, N Koyanagi Y, Matsuo K, Mikami H, Kusakabe M, Takeuchi K, Wakai K.
Associations of metabolic syndrome and metabolically unhealthy obesity with cancer mortality: The Japan Multi-Institutional Collaborative Cohort (J-MICC) study.
PLoS ONE, 2022; 17(7): e0269550.
[PMID: 35802721, PMCID: PMC9269937, DOI: 10.1371/journal.pone.0269550]

81. Saita K, Sumitani M, Nishizawa D, Tamura T, Ikeda K, Wakai K, Sudo Y, Abe H, Otonari J, Ikezaki H, Takeuchi K, Hisida A, Tanaka K, Shimanoe C, Takezaki T, Ibusuki R, Oze I, Ito H, Ozaki E, Matsui D, Nakamura Y, Kusakabe M, Suzuki S, Nakagawa-Senda H, Arisawa K, Katsuura-Kamano S, Kuriki K, Kita Y, Nakamura Y, Momozawa Y, Uchida K.
Genetic polymorphism of pleiotrophin is associated with pain experience in Japanese adults: case-control study.
Medicine, 2022; 101(37): e30580.
[PMID: 36123890, PMCID: PMC9478341, DOI: 10.1097/MD.0000000000030580]

82. Ohta A, Ogawa E, Murata M, Matsumoto Y, Yamasaki S, Ikezaki H, Furusyo N.
Impact of the PNPLA3 genotype on the risk of hepatocellular carcinoma after hepatitis C virus eradication.
Journal of Medical Virology, 2022; 94(10): 5007-14.
[PMID: 35652276, DOI: 10.1002/jmv.27904]

83. Nakamura Y, Tamura T, Narita A, Shimizu A, Sutoh Y, Takashima N, Matsui K, Miyagawa N, Kadota A, Miura K, Otonari J, Ikezaki H, Hishida A, Nagayoshi M, Okada R, Kubo Y, Tanaka K, Shimanoe C, Ibusuki R, Nishimoto D, Oze I, Ito H, Ozaki E, Matsui D, Mikami H, Kusakabe M, Suzuki S, Watanabe M, Arisawa K, Katsuura-Kamano S, Kuriki K, Nakatochi M, Momozawa Y, Kubo M, Takeuchi K, Wakai K & J-MICC Research Group Consortium.
A genome-wide association study on adherence to low-carbohydrate diets in Japanese.
European Journal of Clinical Nutrition, 2022; 76(8): 1103-10.
[PMID: 35132194, DOI: 10.1038/s41430-022-01090-w]

84. Omichi C, Koyama T, Kadotani H, Ozaki E, Tomida S, Yoshida T, Otonari J, Ikezaki H, Hara M, Tanaka K, Tamura T, Nagayoshi M, Okada R, Kubo Y, Oze I, Matsuo K, Nakamura Y, Kusakabe M, Ibusuki R, Shibuya K, Suzuki S, Watanabe M, Kuriki K, Takashima N, Kadota A, Katsuura-Kamano S, Arisawa K, Takeuchi K, Wakai K.
Irregular sleep and all-cause mortality: A large prospective cohort study.
Sleep Health, 2022; 8(6): 678-83.
[PMID: 36229362, DOI: 10.1016/j.sleh.2022.08.010]

85. Sogawa R, Shimanoe C, Tanaka K, Hara M, Nishida Y, Furukawa T, Nagayoshi M, Hishida A, Kubo Y, Kato Y, Oze I, Ito H, Nakamura Y, Kusakabe M, Tanoue S, Koriyama C, Suzuki S, Otani T, Matsui D, Watanabe I, Kuriki K, Takashima N, Kadota A, Watanabe T, Arisawa K, Ikezaki H, Otonari J, Wakai K, Matsuo K, for the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study.
Sex- and age-specific all-cause mortality in insomnia with hypnotics: Findings from Japan multi-institutional Collaborative Cohort Study.
Sleep Medicine, 2022; 100: 410-8.
[PMID: 36240602, DOI: 10.1016/j.sleep.2022.09.020]

86. Ikezaki H, Nomura H, Shimono N.
Dynamics of anti-spike IgG antibody after a third BNT162b2 COVID-19 vaccination in Japanese health care workers.
Heliyon, 2022; 8(12): e12125.
[PMID: 36506407, PMCID: PMC9726652, DOI: 10.1016/j.heliyon.2022.e12125]

87. Sasaki K, Murata M, Nakamura K, Matsumoto Y, Nakashima Y, Yamasaki S, Ota A, Hiramine S, Takayama K, Ikezaki H, Toyoda K, Ogawa E, Shimono N.
A case of severe COVID-19 with pulmonary thromboembolism related to heparin-induced thrombocytopenia during prophylactic anticoagulation therapy.
J Infect Chemother, 2022; 28(8): 1208-11.
[PMID: 35570112, PMCID: PMC9091339, DOI: 10.1016/j.jiac.2022.05.001]

88. Toyoda Y, Nakatochi M, Nakayama A, Kawamura Y, Nakaoka H, Wakai K, Matsuo K, Matsuo H; Japan Gout Genomics Consortium (Japan Gout).
SNP-based heritability estimates of gout and its subtypes determined by genome-wide association studies of clinically defined gout.
Rheumatology, 2023; 62(5): e144-6.
[PMID: 36250897, DOI: 10.1093/rheumatology/keac597]

89. Schaefer EJ*, Ikezaki H*, Diffenderfer MR, Lim E, Liu CT, Hoogeveen RC, Guan W, Tsai MY, Ballantyne CM. * joint first authorship
Atherosclerotic Cardiovascular Disease Risk and Small Dense Low-Density Lipoprotein Cholesterol in Men, Women, African Americans and Non-African Americans: The Pooling Project.
Atherosclerosis, 2023; 367: 15-23.
[PMID: 36724690, DOI: 10.1016/j.atherosclerosis.2023.01.015]

90. Nagayoshi M, Hishida A, Shimizu T, Kato Y, Kubo Y, Okada R, Tamura T, Otonari J, Ikezaki H, Hara M, Nishida Y, Oze I, Koyanagi YN, Nakamura Y, Kusakabe M, Ibusuki R, Shibuya K, Suzuki S, Nishiyama T, Koyama T, Ozaki E, Kuriki K, Takashima N, Nakamura Y, Katsuura-Kamano S, Arisawa K, Nakatochi M, Momozawa Y, Takeuchi K, Wakai K.
BMI and cardiometabolic traits in Japanese: a Mendelian randomization study.
J Epidemiol, 2024; 34(2): 51-62.
[PMID: 36709979, DOI: 10.2188/jea.JE20220154]

91. Kitaoka K, Miura K, Takashima N, Kadota A, Harada A, Nakamura Y, Kita Y, Yano Y, Tamura T, Nagayoshi M, Okada R, Kubo Y, Suzuki S, Nishiyama T, Tanoue S, Koriyama C, Kuriki K, Arisawa K, Katsuura-Kamano S, Nishida Y, Shimanoe C, Ozaki E, Matsui D, Ikezaki H, Otonari J, Oze I, Koyanagi YN, Nakamura Y, Kusakabe M, Wakai K, Matsuo K; J-MICC Research Group.
Association between Dietary Patterns and Serum Low Density Lipoprotein Cholesterol in Japanese Women and Men: The Japan Multi-Institutional Collaborative Cohort (J-MICC) Study.
J Atheroscler Thromb, 2023; 30(10): 1427-47.
[PMID: 36725019, DOI: 10.5551/jat.63675]

92. Nakamura S, Fang X, Saito Y, Narimatsu H, Ota A, Ikezaki H, Shimanoe C, Tanaka K, Kubo Y, Tsukamoto M, Tamura T, Hishida A, Oze I, Koyanagi YN, Nakamura Y, Kusakabe M, Takezaki T, Nishimoto D, Suzuki S, Otani T, Kuriyama N, Matsui D, Kuriki K, Kadota A, Nakamura Y, Arisawa K, Katsuura-Kamano S, Nakatochi M, Momozawa Y, Kubo M, Takeuchi K, Wakai K.
Effects of gene-lifestyle interactions on obesity based on a multi-locus risk score: A cross-sectional analysis.
PLoS One, 2023; 18(2): e0279169.
[PMID: 36753494, PMCID: PMC9907830, DOI: 10.1371/journal.pone.0279169]

93. Kurasawa S, Imaizumi T, Maruyama S, Tanaka K, Kubo Y, Nagayoshi M, Ikezaki H, Suzuki S, Koyama T, Koriyama C, Kadota A, Katsuura-Kamano S, Kuriki K, Wakai K, Matsuo K.
Association of kidney function with cancer incidence and its effects on cancer risk of smoking: the Japan Multi-Institutional Collaborative Cohort Study.
Int J Cancer, 2023; 153(4): 732-41.
[PMID: 37158671, DOI: 10.1002/ijc.34554]

94. Hanyuda A, Goto A, Katagiri R, Koyanagi YN, Nakatochi M, Sutoh Y, Nakano S, Oze I, Ito H, Yamaji T, Sawada N, Iwagami M, Kadota A, Koyama T, Katsuura-Kamano S, Ikezaki H, Tanaka K, Takezaki T, Imoto I, Suzuki M, Momozawa Y, Takeuchi K, Narita A, Hozawa A, Kinoshita K, Shimizu A, Tanno K, Matsuo K, Tsugane S, Wakai K, Sasaki M, Yamamoto M, Iwasaki M.
Investigating the association between glycaemic traits and colorectal cancer in the Japanese population using Mendelian randomization.
Sci Rep, 2023; 13(1): 7052.
[PMID: 37120602, PMCID: PMC10148817, DOI: 10.1038/s41598-023-33966-7]

95. Ikezaki H, Nomura H, Shimono N.
Impact of peripheral mitochondrial DNA level on immune response after COVID-19 vaccination.
iScience, 2023; 26(7): 107094.
[PMID: 37351502, PMCID: PMC10256584, DOI: 10.1016/j.isci.2023.107094]

96. Tamura T, Wakai K, Kato Y, Tamada Y, Kubo Y, Okada R, Nagayoshi M, Hishida A, Imaeda N, Goto C, Ikezaki H, Otonari J, Hara M, Tanaka K, Nakamura Y, Kusakabe M, Ibusuki R, Koriyama C, Oze I, Ito H, Suzuki S, Nakagawa-Senda H, Ozaki E, Matsui D, Kuriki K, Kondo K, Takashima N, Watanabe T, Katsuura-Kamano S, Matsuo K; for the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study.
Dietary carbohydrate and fat intakes and risk for all-cause, cancer, and cardiovascular disease mortality in the Japanese population: the Japan Multi-Institutional Collaborative Cohort Study.
J Nutr, 2023; 153(8): 2352-68.
[PMID: 37271417, DOI: 10.1016/j.tjnut.2023.05.027]

97. Sakashita T, Nakamura Y, Sutoh Y, Shimizu A, Hachiya T, Otsuka-Yamasaki Y, Takashima N, Kadota A, Miura K, Kita Y, Ikezaki H, Otonari J, Tanaka K, Shimanoe C, Koyama T, Watanabe I, Suzuki S, Nakagawa-Senda H, Hishida A, Tamura T, Kato Y, Okada R, Kuriki K, Katsuura-Kamano S, Watanabe T, Tanoue S, Koriyama C, Oze I, Koyanagi YN, Nakamura Y, Kusakabe M, Nakatochi M, Momozawa Y, Wakai K, Matsuo K.
Comparison of the loci associated with HbA1c and blood glucose levels identified by a genome wide association study in the Japanese population.
Diabetol Int, 2023; 14(2): 188-98.
[PMID: 37090135, PMCID: PMC10113415, DOI: 10.1007/s13340-023-00618-0]

98. Ikezaki H, Furusyo N, Ai M, Okazaki M, Kohzuma T, Hayashi J, Shimono N, Schaefer EJ.
Relationship between the cholesterol and triglyceride content of lipoprotein subclasses and carotid intima-media thickness: a cross-sectional population-based study.
Clin Chim Acta, 2023; 548: 117521.
[PMID: 37597644, DOI: 10.1016/j.cca.2023.117521]

99. Tsukamoto M, Hishida A, Tamura T, Nagayoshi M, Okada R, Kubo Y, Kato Y, Hamajima N, Nishida Y, Shimanoe C, Ibusuki R, Shibuya K, Takashima N, Nakamura Y, Kusakabe M, Nakamura Y, Koyanagi YN, Oze I, Nishiyama T, Suzuki S, Watanabe I, Matsui D, Otonari J, Ikezaki H, Katsuura-Kamano S, Arisawa K, Kuriki K, Nakatochi M, Momozawa Y, Takeuchi K, Wakai K, Matsuo K.
GWAS of folate metabolism with gene-environment interaction analysis revealed the possible role of lifestyles in the control of blood folate metabolites in Japanese – the J-MICC Study.
J Epidemiol, 2024; 34(5): 228-37.
[PMID: 37517992, DOI: 10.2188/jea.JE20220341]

100. Nishimoto D, Ibusuki R, Shimoshikiryo I, Shibuya K, Tanoue S, Koriyama C, Takezaki T, Oze I, Ito H, Hishida A, Tamura T, Kato Y, Tamada Y, Nishida Y, Shimanoe C, Suzuki S, Nishiyama T, Ozaki E, Tomida S, Kuriki K, Miyagawa N, Kondo K, Arisawa K, Watanabe T, Ikezaki H, Otonari J, Wakai K, Matsuo K.
Association between awareness of limiting food intake and all-cause mortality: A cohort study in Japan.
J Epidemiol 2024; 34(6): 286-94.
[PMID: 37926519, DOI: 10.2188/jea.JE20220354]

101. Matsumoto Y, Murata M, Ohta A, Yamasaki S, Ikezaki H, Toyoda K, Shimono N.
The humoral and cellular immune responses following booster vaccination with SARS-CoV-2 mRNA in people living with human immunodeficiency virus.
J Infect Chemother 2024; 30(5): 417-22.
[PMID: 37977325, DOI: 10.1016/j.jiac.2023.11.014]

102. Tomida S, Koyama T, Ozaki E, Takashima N, Morita M, Sakaguchi K, Naoi Y, Nishida Y, Hara M, Hishida A, Tamura T, Okada R, Kubo Y, Otonari J, Ikezaki H, Nakamura Y, Kusakabe M, Tanoue S, Koriyama C, Koyanagi YN, Ito H, Suzuki S, Otani T, Miyagawa N, Okami Y, Arisawa K, Watanabe T, Kuriki K, Wakai K, Matsuo K.
Seven-plus hours of daily sedentary time and the subsequent risk of breast cancer: Japan Multi-Institutional Collaborative Cohort Study.
Cancer Sci 2024; 115(2): 611-22.
[PMID: 38041484, PMCID: PMC10859602, DOI: 10.1111/cas.16020]

103. Koyanagi YN, Nakatochi M, Namba S, Oze I, Charvat H, Narita A, Kawaguchi T, Ikezaki H, Hishida A, Hara M, Takezaki T, Koyama T, Nakamura Y, Suzuki S, Katsuura-Kamano S, Kuriki K, Nakamura Y, Takeuchi K, Hozawa A, Kinoshita K, Sutoh Y, Tanno K, Shimizu A, Ito H, Kasugai Y, Kawakatsu Y, Taniyama Y, Tajika M, Shimizu Y, Suzuki E, Hosono Y, Imoto I, Tabara Y, Takahashi M, Setoh K; BioBank Japan Project; Matsuda K, Nakano S, Goto A, Katagiri R, Yamaji T, Sawada N, Tsugane S, Wakai K, Yamamoto M, Sasaki M, Matsuda F, Okada Y, Iwasaki M, Brennan P, Matsuo K.
Genetic architecture of alcohol consumption identified by a genotype-stratified GWAS and impact on esophageal cancer risk in Japanese people.
Sci Adv 2024; 10(4): eade2780.
[PMID: 38277453, PMCID: PMC10816704, DOI: 10.1126/sciadv.ade2780]

104. Hishida A, Nakatochi M, Sutoh Y, Nakano S, Momozawa Y, Narita A, Tanno K, Shimizu A, Hozawa A, Kinoshita K, Yamaji T, Goto A, Noda M, Sawada N, Ikezaki H, Nagayoshi M, Hara M, Suzuki S, Koyama T, Koriyama C, Katsuura-Kamano S, Kadota A, Kuriki K, Yamamoto M, Sasaki M, Iwasaki M, Matsuo K, Wakai K.
GWAS meta-analysis of kidney function traits in Japanese populations.
J Epidemiol 2024; Apr 6. Online ahead of print.
[PMID: 38583947, DOI: 10.2188/jea.JE20230281]

105. Kasahara C, Tamura T, Wakai K, Tamada Y, Kato Y, Kubo Y, Okada R, Nagayoshi M, Hishida A, Imaeda N, Goto C, Otonari J, Ikezaki H, Nishida Y, Shimanoe C, Oze I, Koyanagi YN, Nakamura Y, Kusakabe M, Nishimoto D, Shimoshikiryo I, Suzuki S, Watanabe M, Ozaki E, Omichi C, Kuriki K, Takashima N, Miyagawa N, Arisawa K, Katsuura-Kamano S, Takeuchi K, Matsuo K; J-MICC Study Group.
Association between consumption of small fish and all-cause mortality among Japanese: the Japan Multi-Institutional Collaborative Cohort Study.
Public Health Nutr 2024; 27(1): e135.
[PMID: 38698584, DOI: 10.1017/S1368980024000831]

106. Fujii R, Hishida A, Nakatochi M, Okumiyama H, Takashima N, Tsuboi Y, Suzuki K, Ikezaki H, Shimanoe C, Kato Y, Tamura T, Ito H, Michihata N, Tanoue S, Suzuki S, Kuriki K, Kadota A, Watanabe T, Momozawa Y, Wakai K, Matsuo K, for the J-MICC Study Group.
Polygenic risk score for blood pressure and lifestyle factors with overall and CVD mortality: A prospective cohort study in a Japanese population.
Hypertension Res 2024; 47(9): 2284-94.
[PMID: 38961281, DOI: 10.1038/s41440-024-01766-9]

107. Yamasaki S, Murata M, Ohta A, Matsumoto Y, Ikezaki H, Furusyo N.
Analyses of the association between Helicobacter pylori antibody titer and pathogenicity before and after eradication: results of the Kyushu and Okinawa population study, a retrospective observational cohort study.
BMJ Open 2024; 14(8): e083157.
[PMID: 39117418, DOI: 10.1136/bmjopen-2023-083157]

108. Matsunaga T, Wakai K, Imaeda N, Goto C, Tamada Y, Kato Y, Kubo Y, Okada R, Nagayoshi M, Tamura T, Hishida A, Ikezaki H, Otonari J, Takashima N, Miyagawa N, Matsuo K; Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group.
Food group intakes and high-sensitivity C-reactive protein among community-dwelling Japanese adults: a cross-sectional study.
Public Health Nutr 2024; 27: e212.
[PMID: 39420779, PMCID: PMC11604322, DOI: 10.1017/S1368980024001599]

109. Miyagawa N, Takashima N, Harada A, Kadota A, Kondo K, Miura K, Imaeda N, Goto C, Otonari J, Ikezaki H, Tanaka K, Shimanoe S, Nagayoshi M, Tamura T, Kubo Y, Kato Y, Koyanagi YN, Ito H, Michihata N, Nakamura Y, Tanoue S, Ibusuki R, Suzuki S, Nishiyama T, Ozaki E, Watanabe I, Kuriki K, Watanabe T, Ishizu M, Hishida A, Kita Y, Wakai K, Matsuo K, and J-MICC Study Group.
Dairy Intake and All-Cause, Cancer, and Cardiovascular Disease Mortality Risk in A Large Japanese Population: A 12-Year Follow-Up of the J-MICC Study.
J Atheroscler Thromb 2025; 32(5): 596-607.
[PMID: 39537182, DOI: 10.5551/jat.65049]

110. Ikezaki H, Nakashima R, Matsumoto Y, Ohta A, Yamasaki S, Hiramine S, Takayama K, Ogawa E, Murata M, Furusyo N, Hayashi J, Shimono N, Schaefer EJ.
Impact of NAFLD-related SNPs on the carotid atherosclerosis development; a five-year prospective observational study.
Atherosclerosis Plus 2024; 59: 10-7.
[PMID: 39802653, PMCID: PMC11719292, DOI: 10.1016/j.athplu.2024.12.003]

111. Fujii R, Nagayoshi M, Nakatochi M, Sato S, Tsuboi Y, Suzuki K, Ikezaki H, Nishida Y, Kubo Y, Tanoue S, Suzuki S, Koyama T, Kuriki K, Takashima N, Katsuura-Kamano S, Momozawa Y, Wakai K, Matsuo K, for the J-MICC Study Group.
Multi-trait polygenic risk score, non-genetic determinants, and cardiovascular disease mortality: A cohort study of 14,086 Japanese individuals.
JAHA: Journal of the American Heart Association 2025; 14: e038572.
[PMID: 40079315, DOI: 10.1161/JAHA.124.038572]

112. Yamamoto S, Koyanagi YN, Iwashita Y, Shinozaki T, Fujiwara Y, Sakakura N, Hara M, Nishida Y, Otonari J, Ikezaki H, Tanoue S, Koriyama C, Kasugai Y, Oze I, Koyama T, Tomida S, Michihata N, Nakamura Y, Suzuki S, Nakagawa-Senda H, Nagayoshi M, Kubo Y, Kato Y, Wakai K, Watanabe T, Ishizu M, Takashima N, Kadota A, Momozawa Y, Nakatochi M, Tamura T, Niimi A, Ito H, Matsuo K.
Smoking Behavior-related Genetic Variants and Lung Cancer Risk in Japanese: an Assessment by Mediation Analysis.
Carcinogenesis 2025; 46(2): bgaf011.
[PMID: 40059777, DOI: 10.1093/carcin/bgaf011]

113. Goto C, Imaeda N, Wakai K, Sasakabe T, Michihata N, Oze I, Hosono A, Nagayoshi M, Miyagawa N, Ozaki E, Ikezaki H, Nanri H, Ibusuki R, Katsuura-Kamano S, Kuriki K, Yaguchi Y, Kurihara A, Matsuo K.
Reproducibility and validity of a food frequency questionnaire for nutrient intakes in the study areas of large-scale cohort studies in Japan.
Nagoya J Med Sci, 2025; 87: 237-253.
[PMID: 40765806, DOI: 10.18999/nagjms.87.2.237]

114. Hoogeveen RC, Diffenderfer MR, Lim E, Liu CT, Ikezaki H, Guan W, Tsai MY, Ballantyne CM.
Lp(a) and Risk for Atherosclerotic Cardiovascular Disease: Impact of High-Sensitivity CRP and Risk Variability among Human Clinical Subgroups.
Nutrients, 2025; 17: 1324.
[PMID: 40284189, PMCID: PMC12030245, DOI: 10.3390/nu17081324]

115. Nomura S, Guan W, Zhang Y, Tison G, Ikezaki H, Diffenderfer M, Liu CT, Hoogeveen RC, Ballantyne CM, Schaefer EJ.
Lipoprotein(a) and Heart Failure among Black and White Participants in Atherosclerosis Risk in Communities Study, Framingham Offspring Study and Multi-Ethnic Study of Atherosclerosis: The Pooling Project.
JAHA, 2025, 14(11): e038608.
[PMID: 40417812, DOI: 10.1161/JAHA.124.038608]

116. Furukawa T, Hara M, Nishida Y, Tanaka K, Shimanoe C, Iwasaka C, Otonari J, Ikezaki H, Nagayoshi M, Tamura T, Tamada Y, Okada R, Oze I, Ito H, Michihata N, Nakamura Y, Tanoue S, Koriyama C, Suzuki S, Otani T, Watanabe I, Tomida S, Kuriki K, Takashima N, Kadota A, Ishizu M, Watanabe T, Nakatochi M, Momozawa Y, Wakai K, Matsuo K; Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group.
Comparison of polygenic risk scores for type 2 diabetes developed from different ancestry groups.
NPJ Metab Health Dis, 2025; 3(1): 17.
[PMID: 40603767, PMCID: PMC12118717, DOI: 10.1038/s44324-025-00059-0]

117. Namba S, Sonehara K, Koyanagi YN, Kikuchi T, Ojima T, Edahiro R, Sato G, Yamaji T, Tomofuji Y, Ueda H, Yamamoto K, Ogawa Y, Suzuki K, Kanai A, Higashiue S, Kobayashi S, Yamaguchi H, Nagata Y, Okazaki Y, Matumoto N, Motomura K, Koga H, Hishida A, Ikezaki H, Hara M, Nagayoshi M, Oze I, Nakano S, the BioBank Japan Project, Oda Y, Suzuki Y, Iwasaki M, Sawada N, Matsuo K, Morisaki T, Yamauchi T, Kadowaki T, Matsuda K, Okada Y.
A Cross-population Compendium of Gene–Environment Interactions.
Nature, 2026; 651(8106): 688-97.
[PMID: 41606330, DOI: 10.1038/s41586-025-10054-6]

118. Htay ZW, Michihata N, Nakamura Y, Hippo Y, Otonari J, Ikezaki H, Nishida Y, Shimanoe C, Tamura T, Nagayoshi M, Kato Y, Tamada Y, Hishida A, Tanoue S, Nishimoto D, Koyama T, Ozaki E, Kuriki K, Takashima N, Miyagawa N, Katsuura-Kamano S, Watanabe T, Wakai K, Matsuo K.
Dietary diversity and the risk of metabolic syndrome in a Japanese population: an analysis of baseline cross-sectional data from the J-MICC study.
Eur J Clin Nutr 2025; 79(11): 1106-13.
[PMID: 40813466, DOI: 10.1038/s41430-025-01654-6]

119. Kawahara T, Nawa N, Oze I, Ikezaki H, Hara M, Kubo Y, Nagayoshi M, Ito H, Michihata N, Ibusuki R, Suzuki S, Ozaki E, Kuriki K, Takashima N, Katsuura-Kamano S, Nakatochi M, Momozawa Y, Tamura T, Fujiwara T, Matsuo K; J-MICC Study Group.
Inverse association between fruit juice consumption and type 2 diabetes among individuals with high genetic risk on type 2 diabetes: the Japan Multi-Institutional Collaborative Cohort (J-MICC) study.
Br J Nutr 2025; 134(2): 89-96.
[PMID: 40637492, DOI: 10.1017/S0007114525103863]

120. Unohara T, Watanabe T, Arisawa K, Matsuura A, Kita K, Torii Y, Ishizu M, Katsuura-Kamano S, Nguyen TV, Otonari J, Ikezaki H, Tanaka K, Shimanoe C, Nagayoshi M, Kubo Y, Matsunaga T, Okada R, Oze I, Ito H, Michihata N, Nakamura Y, Tanoue S, Koriyama C, Suzuki S, Nishiyama T, Koyama T, Ozaki E, Kuriki K, Takashima N, Kondo K, Tamura T, Matsuo K.
Dietary acid load and mortality: Results from the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study.
Sci Rep 2025; 15(1): 41297.
[PMID: 41271855, DOI: 10.1038/s41598-025-25081-6]

121. Shibuya K, Ibusuki R, Nishimoto D, Tanoue S, Koriyama C, Niiyama S, Kakihana Y, Takezaki T, Hara M, Nishida Y, Suzuki S, Nishiyama T, Nagayoshi M, Tamura T, Tamada Y, Okada R, Koyama T, Tomida S, Kuriki K, Otonari J, Ikezaki H, Hishida A, Ishizu M, Katsuura-Kamano S, Wakai K, Matsuo K, for the J-MICC Study group.
Serum albumin and gamma gap levels, and combined effect for risk of mortality in a Japanese population from the J-MICC study.
PLOS ONE 2025; 20(11): e0336926.
[PMID: 41248155, DOI: 10.1371/journal.pone.0336926]

122. Matsuura A, Watanabe T, Torii Y, Kita K, Unohara T, Ishizu M, Otonari J, Ikezaki H, Hara M, Nishida Y, Nagayoshi M, Wakai K, Kato Y, Matsunaga T, Koyanagi YN, Oze I, Michihata N, Nakamura Y, Koriyama C, Nishimoto D, Suzuki S, Otani T, Takashima N, Ozaki E, Kuriki K, Miyagawa N, Kondo K, Tamura T, Matsuo K, for the J-MICC Study Group.
Nutrient patterns and mortality: Results from the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study.
Nutrition Journal 2025; 25(1): 10.
[PMID: 41382287, DOI: 10.1186/s12937-025-01274-7]

123. Brou MAMBE, Fujiyoshi A, Higashiyama A, Okami Y, Kita Y, Miura K, Ikezaki H, Furukawa T, Tamura T, Nishimoto D, Nishiyama T, Takashima N, Kuriki K, Ishizu M, Lin Y, Kasugai Y, Koyanagi YN, Oze I, Matsuo K, for the JMICC Study Group.
Liver Diseases and Low Serum Albumin as Potential Confounders in the Association Between Low Total Cholesterol and Elevated All-cause and Cancer Mortality: The Japan Multi-Institutional Collaborative Cohort (J-MICC) Study.
J Clin Lipidol, 2026; 20(2): 357-67.
[PMID: 41484028, DOI: 10.1016/j.jacl.2025.11.009]

124. Okumiyama H, Fujii R, Nagayoshi M, Nakatochi M, Tsuboi Y, Suzuki K, Ikezaki H, Furukawa T, Okada R, Tanoue S, Suzuki S, Koyama T, Kuriki K, Takashima N, Watanabe T, Hishida A, Momozawa Y, Sakurai-Yageta M, Shimizu A, Wakai K, Matsuo K, for the J-MICC Study Group.
Integration of polygenic risk score with measured blood pressure reveals hidden risks of cardiovascular disease mortality: a Japanese prospective cohort study.
Hypertens Res, 2026; 49(3): 585-95.
[PMID: 41444827, DOI: 10.1038/s41440-025-02486-4]

125. Kato Y, Tamura T, Wakai K, Kubo Y, Okada R, Matsunaga T, Nagayoshi M, Imaeda N, Goto C, Otonari J, Ikezaki H, Hara M, Nishida Y, Michihata N, Nakamura Y, Tanoue S, Ibusuki R, Suzuki S, Otani T, Koyanagi YN, Ito H, Ozaki E, Watanabe I, Kuriki K, Takashima N, Miyagawa N, Katsuura-Kamano S, Watanabe T, Hishida A, Matsuo K.
Associations of vegetable and fruit consumption with all-cause and cause-specific mortality in the Japanese population: the Japan multi-institutional collaborative cohort study.
Nutrition Journal 2025; 25(1): 2.
[PMID: 41275208, DOI: 10.1186/s12937-025-01257-8]

126. Ikezaki H, Nakashima R, Takase K, Eiraku K, Fujimoto Y, Hayashi J, Nomura H, Shimono N.
Efficacy and Safety of Imeglimin in Elderly Patients with Type 2 Diabetes: A Retrospective Real-World Study.
Journal of Hospital General Medicine; 2026; 8: 112-20.
[DOI: 10.60227/jhgmeibun.2025-0096]

127. Hara M, Hachiya T, Furukawa T, Nishida Y, Tanaka K, Shimanoe C, Otonari J, Ikezaki H, Wakai K, Matsunaga T, Ito H, Yamamoto S, Michihata N, Nakamura Y, Tanoue S, Hidaka Y, Nishiyama T, Nakagawa H, Takashima N, Matsui D, Kuriki K, Miura K, Matsui K, Watanabe T, Watanabe K, Kageyama I, Nakatochi M, Momozawa Y, Okada R, Koyanagi YN, Oze I, Matsuo K.
Predictive Performance of Breast Cancer Polygenic Risk Scores from Diverse Ancestries: A Prospective Study in Japanese Women.
Breast Cancer Research 2026 accepted.

128. Ikezaki H, Nakashima R, Nomura H, Shimono N.
Association of Mitochondrial DNA Levels in Peripheral Blood Leukocytes with Physical Performance in Older Adults.
Geriatrics & Gerontology International 2026; 26(4): e70484.
[PMID: 41978339, PMCID: PMC13077262, DOI: 10.1111/ggi.70484]

129. Zhang Y, Schaefer EJ, Ikezaki H, Diffenderfer MR, Lloyd-Jones DM, Hoogeveen RC, Ballantyne CM, Guan W, Tsay MY, Liu CT.
A Comprehensive Evaluation of Atherosclerotic Cardiovascular Disease Risk Predictors Across the Pooled Cohort Equation, PREVENT, and an Expanded Model.
JAHA 2026 accepted.
[DOI: 10.1161/JAHA.125.049726]

1.多臓器転移AIDS関連カポジ肉腫の1例
(感染症学雑誌 2011; 85(1): 54-8)
池崎裕昭、小川栄一、村田昌之、居原　毅、豊田一弘、谷合啓明、大田黒　滋、澤山泰典、古庄憲浩、林　純

2.消化管Kaposi肉腫を合併したHIV感染症の2例
(胃と腸 2011; 46(3): 303-9)
小川栄一、村田昌之、池崎裕昭、居原　毅、髙山耕治、豊田一弘、貝沼茂三郎、澤山泰典、古庄憲浩、江崎幹宏、松本主之、後藤綾子、山元英崇、林　純

3.骨髄不全症候群を基礎とした輸血歴のない続発性ヘモクロマトーシスの1例
(臨床と研究 2012; 89(5): 654-8)
池崎裕昭、古庄憲浩、大田黒　滋、居原　毅、小川栄一、豊田一弘、谷合啓明、貝沼茂三郎、岡田享子、村田昌之、澤山泰典、林　純

4.インターフェロン先行投与後の抗レトロウイルス療法により免疫再構築症候群の発症なくHBs抗原の陰性化が得られたHBV/HIV重複感染の1例
(感染症学雑誌 2012; 86(6): 763-7)
池崎裕昭、古庄憲浩、大田黒　滋、居原　毅、小川栄一、豊田一弘、谷合啓明、貝沼茂三郎、岡田享子、村田昌之、澤山泰典、林　純

5.血清cholesterol値の急激な低下を契機に診断されたS状結腸癌の1例
(日本病院総合診療医学会雑誌 2018; 14(5): 522-4)
林　純、加勢田富士子、池崎裕昭、小森彩佳、上山貴嗣、坂本篤彦

6.A case of successfully treated invasive pulmonary aspergillosis following influenza B infection: A case report and literature review.
(Journal of General Hospital Medicine 2020; 2(3): 71-7)
Ikezaki H, Fujita A, Aoto A, Itoh M, Nakamichi M, Kaseida F, Miyoshi K, Sakamoto A, Murata M, Hayashi J.

1.身体所見のメカニズム A to Zハンドブック (Mechanisms of CLINICAL SIGNS 2nd edition)
第7章: 内分泌系の所見
エルゼビア・ジャパン, 東京. 2019: 647-716
翻訳: 池崎裕昭, 監訳: 内藤俊夫

2.臨床雑誌 内科　患者の将来を見据えた実践的糖尿病診療－脱“血糖屋さん”のススメ
Chapter 3 血糖値だけではない糖尿病併存症の診断・予防・治療
糖尿病患者における動脈硬化性疾患の診断・予防・治療
南江堂, 東京. 2024; 133(5): 1155-8
池崎裕昭

3.脂質異常症の診かた、考え方
中外医学社, 東京. 2026
池崎裕昭

1.総合診療医が担う脂質異常症診療
日本病院総合診療医学会雑誌 2021; 17(3): 326-34.
池崎裕昭、Schaefer EJ、林　純.

1.The relationship between plasma glycated albumin level and atherosclerosis: results from the Kyushu and Okinawa population study (KOPS).
(47th Annual Meeting European Association for the Study of Diabetes, Lisbon, Portugal, 2011.9.12～9.16)
Ikezaki H, Furusyo N, Koga T, Ai M, Otokozawa T, Kohzuma T, Schaefer EJ, Hayashi J

2.Natural human interferon-beta plus ribavirin treatment toleration by chronic hepatitis C patients with depression or thrombocytopenia.
(ID Week 2013, San Francisco, CA, USA, 2013.10.2～10.6)
Ikezaki H, Furusyo N, Hiramine S, Ogawa E, Murata M, Hayashi J

3.Cardiovascular Disease Prevalence and Risk Factors in Japanese and American Populations.
(ATVB/PVD 2016, Nashville, TN, USA, 2016.5.5～5.7)
Ikezaki H, Ai M, Schaefer EJ, Otokozawa S, Asztalos BF, Nakajima K, Yanhua Z, Liu CT, Jacques PF, Cupples LA, Furusyo N

4.Prevalence of Diabetes and Prediabetes in the Kyushu-Okinawa Population Study and the Framingham Offspring Study.
(ADA 76th Scientific Sessions, New Orleans, LA, USA, 2016.6.10～6.14)
Ikezaki H, Ai M, Schaefer EJ, Otokozawa S, Asztalos BF, Nakajima K, Yanhua Z, Liu CT, Jacques PF, Cupples LA, Furusyo N

5.Impact of food consumption on Helicobacter pylori eradication therapy: a Japanese community-based observational study.
(ID Week 2016, New Orleans, LA, USA, 2016.10.26～10.30)
Ikezaki H, Furusyo N, Jacques PF, Murata M, Schaefer EJ, Urita Y, Hayashi J

6.Remnant Lipoprotein Cholesterol and Other Lipoprotein Levels in Coronary Heart Disease Cases and Controls: Results from the Framingham Offspring Study.
(5th International Symposium on Chylomicrons in Diseases, Boston, MA, USA, 2016.11.9～11.10)
IIkezaki H, Fisher V, Cupples LA, Minagawa A, Ito Y, Schaefer EJ

7.Hyperinsulinemia and Cardiovascular Disease in Japan and the United States.
(AHA Scientific Session 2016, New Orleans, LA, USA, 2016.11.12～11.16)
Ikezaki H, Ai M, Schaefer EJ, Otokozawa S, Asztalos BF, Nakajima K, Yanhua Z, Liu CT, Jacques PF, Cupples LA, Furusyo N

8.Lipoprotein(a) and Carotid Intimal Medial Thickness.
(ATVB/PVD 2017, Minneapolis, MN, USA, 2017.5.4～5.6)
Ikezaki H, Yokota Y, Schaefer EJ, Horvath KV, Asztalos BF, Furusyo N

9.Direct vs calculated LDL-C and C reactive protein in cardiovascular disease risk assessment in the Framingham Offspring Study.
(ATVB|PVD 2018, San Francisco, CA, USA, 2018.5.10～5.12)
Ikezaki H, Fisher VA, Liu Ct, Cupples LA, Nakajima K, Asztalos BF, Furusyo N, Hayashi J, Schaefer EJ

10.Lipoprotein and cardiovascular disease risk.
(ATVB|PVD 2018, San Francisco, CA, USA, 2018.5.10～5.12)
Ikezaki H, Fisher VA, Liu Ct, Cupples LA, Nakajima K, Asztalos BF, Furusyo N, Schaefer EJ

11.Direct vs calculated LDL-C and C reactive protein in cardiovascular disease risk assessment in the Framingham Offspring Study.
(International Academy of Cardiology Scientific Sessions 2018, Boston, MA, USA, 2018.7.27～7.29)
Ikezaki H, Fisher VA, Liu Ct, Cupples LA, Nakajima K, Asztalos BF, Furusyo N, Hayashi J, Schaefer EJ

12.Low Density Lipoprotein Subfractions, Lipoprotein(a), and Cardiovascular Disease Risk Assessment in the Framingham Offspring Study.
(AHA Scientific Sessions 2018, Chicago, IL, USA, 2018.11.10～11.12)
Ikezaki H, Fisher VA, Liu Ct, Cupples LA, Nakajima K, Asztalos BF, Schaefer EJ

13.Direct Lipoprotein Measurements and Cardiovascular Disease Risk: Results from the Framingham Offspring Study.
(70th AACC Annual Scientific Meeting & Clinical Lab Expo, Chicago, IL, USA, 2018.7.29～8.2)
Schaefer EJ, Ikezaki H, Fisher VA, Nakajima K, Liu CT, Cupples LA

14.Direct Lipoprotein Measurements and Cardiovascular Disease Risk Assessment in the Framingham Offspring Study.
(Vascular Discovery Scientific Sessions 2019, Boston, MA, USA, 2019.5.14～5.16)
Ikezaki H, Fisher VA, Liu Ct, Cupples LA, Nakajima K, Murata M, Furusyo N, Asztalos BF, Schaefer EJ

15.Small Dense Low Density Lipoprotein Cholesterol Predict Carotid Intimal Medial Thickness Progression
(Vascular Discovery Scientific Sessions 2019, Boston, MA, USA, 2019.5.14～5.16)
Ikezaki H, Furusyo N, Yokota Y, Ai M, Asztalos BF, Murata M, Hayashi J, Schaefer EJ

16.Small Dense Low Density Lipoprotein Cholesterol Predict Carotid Intimal Medial Thickness Progression.
(71st AACC Annual Scientific Meeting, Anaheim, CA, USA, 2019.8.4～8.8)
Ikezaki H, Furusyo N, Ito Y, Yokota Y, Ai M, Asztalos BF, Murata M, Hayashi J, Schaefer EJ

17.Small Dense Low Density Lipoprotein Cholesterol Predict Carotid Intimal Medial Thickness Progression.
(42nd Annual Scientific Meeting of the European Lipoprotein Club (ELC), Tutzing, Germany, 2019.9.9～9.12)
Ikezaki H, Furusyo N, Yokota Y, Ai M, Asztalos BF, Murata M, Hayashi J, Schaefer EJ

18.Small dense LDL cholesterol as a cardiovascular risk assessment; results from Framingham Offspring Study.
(AHA Scientific Sessions 2019, Philadelphia, PA, USA, 2019.11.16～11.18)
Ikezaki H, Lim E, Liu CT, Cupples LA, Nakajima K, Asztalos BF, Murata M, Furusyo N, Schaefer EJ

19.Small Dense Low Density Lipoprotein Cholesterol Level Predicts Carotid Intimal Medial Thickness Progression over 5 years.
(AHA Scientific Sessions 2019, Philadelphia, PA, USA, 2019.11.16～11.18)
Ikezaki H, Furusyo N, Yokota Y, Ai M, Asztalos BF, Murata M, Hayashi J, Schaefer EJ

20.Atherogenic Lipoproteins and Incident Atherosclerotic Cardiovascular Disease in the Framingham Offspring Study.
(EPI|LIFESTYLE 2020, Phoenix, AZ, USA, 2020.3.3～3.6)
Ikezaki H, Lim E, Liu CT, Cupples LA, Asztalos BF, Schaefer EJ

21.Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression.
(EPI|LIFESTYLE 2020, Phoenix, AZ, USA, 2020.3.3～3.6)
Ikezaki H, Yokota Y, Ai M, Asztalos BF, Murata M, Hayashi J, Schaefer EJ

22.Atherogenic Lipoproteins and Carotid Intimal Medial Thickness Progression over 5 years.
(88th EAS Congress, Geneva, Switzerland, 2020.10.4～10.7)
Ikezaki H, Yokota Y, Ai M, Asztalos BF, Murata M, Hayashi J, Schaefer EJ

23.Atherogenic Lipoproteins and Atherosclerotic Cardiovascular Disease in the Framingham Offspring Study
(88th EAS Congress, Geneva, Switzerland, 2020.10.4～10.7)
Ikezaki H, Lim E, Liu CT, Cupples LA, Asztalos BF, Schaefer EJ

24.Gender Differences in Lipoprotein Parameters in Cardiovascular Disease Risk; The Framingham Offspring Study
(AHA Scientific Sessions 2020, Dallas, TX, USA, 2020.11.13～11.17)
Ikezaki H, Lim E, Liu CT, Cupples LA, Asztalos BF, Murata M, Furusyo N, Schaefer EJ

25.Relationship between dietary vitamin D intake, obesity, and twenty lipoprotein subclasses: results from the Kyushu and Okinawa Population Study (KOPS).
(89th EAS Congress, Helsinki, Finland, 2021.5.30～6.2)
Ikezaki H, Nakashima R, Ai M, Okazaki M, Kohzuma T, Schaefer EJ

26.Relationship Between the Cholesterol and Triglyceride Content of Lipoprotein Subclasses and Carotid Intima-Media Thickness: Results from the Kyushu and Okinawa Population Study.
(AHA Scientific Sessions 2021, Boston, MA, USA, 2021.11.13～11.15)
Ikezaki H, Furusyo N, Ai M, Okazaki M, Hayashi J, Schaefer EJ

27.Relationship between dietary vitamin D intake, obesity, and twenty lipoprotein subclasses: results from the Kyushu and Okinawa Population Study (KOPS).
(AHA Scientific Sessions 2021, Boston, MA, USA, 2021.11.13～11.15)
Ikezaki H, Nakashima R, Furusyo N, Ai M, Okazaki M, Hayashi J, Schaefer EJ

28.Relationship Between the Cholesterol and Triglyceride Content of Lipoprotein Subclasses and Carotid Intima-Media Thickness: Results from the Kyushu and Okinawa Population Study.
(90th EAS Congress, Milan, Italy (Hybrid), 2022.5.22～5.25)
Ikezaki H, Ai M, Okazaki M, Hayashi J, Shimono N, Schaefer EJ

29.Association Between Nonalcoholic Fatty Liver Disease Risk Alleles And Atherosclerosis.
(AHA Scientific Sessions 2022, Chicago, IL, USA (Hybrid), 2022.11.5～11.7)
Ikezaki H, Schaefer EJ, Murata M, Shimono N

30.Variants of Neurocan, a nonalcoholic fatty liver disease risk allele, are associated with plaque development in the carotid artery over 5 years.
(EPI|Lifestyle 2023, Boston, MA, USA, 2023.2.28～3.3)
Ikezaki H, Schaefer EJ, Murata M, Shimono N

31.Variants of Neurocan, a nonalcoholic fatty liver disease risk allele, are associated with atherosclerosis progression over 5 years.
(Vascular Discovery 2023, Boston, MA, USA, 2023.5.10～5.13)
Ikezaki H, Schaefer EJ, Murata M, Shimono N.

32.Non-alcoholic fatty liver disease risk SNP variants affect lipid metabolism.
(AHA Scientific Sessions 2023, Philadelphia, PA, USA, 2023.11.11～11.13)
Ikezaki H, Murata M, Shimono N, Schaefer EJ.

33.Association between non-alcoholic fatty liver disease risk SNP variants and lipid metabolism.
(EPI|Lifestyle 2024, Chicago, IL, USA, 2024.3.18～3.21)
Ikezaki H, Murata M, Shimono N, Schaefer EJ.

1.多血性で肝動脈塞栓術を施行した肝過形成結節の1症例
(第90回 日本消化器病学会 九州支部例会, 長崎, 2007.11.30～12.1)
池崎裕昭、緒方久修、東　晃一、平川雅和、實藤隼人、平橋高明、梶原英二、飯田三雄

2.全身に浸潤転移を認めたAIDS関連カポジ肉腫
(第17回 日本総合診療医学会学術集会, 福岡, 2009.2.28～3.1)
池崎裕昭、小川栄一、村田昌之、居原　毅、豊田一弘、谷合啓明、大田黒　滋、澤山泰典、古庄憲浩、近藤晴彦、居石克夫、林　純

3.全身に浸潤転移を認めたAIDS関連カポジ肉腫
(第83回 日本感染症学会総会･学術講演会, 東京, 2009.4.23～4.24)
池崎裕昭、小川栄一、村田昌之、居原　毅、豊田一弘、谷合啓明、大田黒　滋、澤山泰典、古庄憲浩、林　純

4.HCV genotype 2型 C型慢性肝炎におけるインターフェロンβ・リバビリン併用療法の成績
(第86回 日本感染症学会総会･学術講演会, 長崎, 2012.4.25～4.26)
池崎裕昭、古庄憲浩、小川栄一、豊田一弘、居原　毅、林　武生、永樂訓三、光本富士子、谷合啓明、貝沼茂三郎、岡田享子、村田昌之、林　純

5.C型慢性肝炎に対するインターフェロンβ・リバビリン併用療法後の肝癌発症調査
(第40回 日本肝臓学会東部会, 東京, 2014.11.27～11.28)
池崎裕昭、野村秀幸、古庄憲浩、小川栄一、中牟田　誠、梶原英二、道免和文、高橋和弘、佐藤丈顕、東　晃一、河野　聡、小柳年正、古藤和浩、下田慎二、林　純

6.食事摂取パターンがヘリコバクター・ピロリ除菌療法に及ぼす影響の検討
(第91回 日本感染症学会総会, 東京, 2017.4.6～4.8)
池崎裕昭、古庄憲浩、志水元洋、村田昌之、瓜田純久、林　純

7.耐糖能異常におけるインスリン分泌能・インスリン抵抗性の人種差の検討
(第60回 日本糖尿病学会総会, 名古屋, 2017.5.18～5.20)
池崎裕昭、藍　真澄、男澤聖子、中嶋克行、村田昌之、古庄憲浩、林　純

8.食事摂取パターンがヘリコバクター・ピロリ除菌療法成功率に与える影響の検討
(第23回 日本ヘリコバクター学会学術集会, 函館, 2017.6.30～7.2)
池崎裕昭、古庄憲浩、村田昌之、渡邊利泰、中嶋　均、瓜田純久、林　純

9.動脈硬化における血清リポタンパク質値の検討－Kyushu and Okinawa Population Study (KOPS)成績より－
(第15回 日本病院総合診療医学会学術総会, 東京, 2017.9.14～9.15)
池崎裕昭、古庄憲浩、上山貴嗣、山嵜　奨、田中佑樹、加藤禎史、村田昌之、林　純

10.冠動脈疾患に関わる危険因子の日米比較の検討
(第15回 日本病院総合診療医学会学術総会, 東京, 2017.9.14～9.15)
池崎裕昭、古庄憲浩、上山貴嗣、山嵜　奨、田中佑樹、加藤禎史、村田昌之、林　純

11.高齢者の意識レベル低下の原因を持続的グルコースモニタリングシステムで低血糖発作と証明できた一例
(第16回 日本病院総合診療医学会学術総会, 別府, 2018.3.2～3.3)
池崎裕昭、藤田敦子、上山貴嗣、小森彩佳、坂本篤彦、林 純

12.Direct vs calculated LDL-C and C reactive protein in cardiovascular disease risk assessment in the Framingham Offspring Study.
(第50回 日本動脈硬化学会総会・学術集会, 大阪, 2018.7.12～7.14)
Ikezaki H, Fisher VA, Liu Ct, Cupples LA, Nakajima K, Schaefer EJ, Furusyo N, Hayashi J

13.繰り返す低血糖発作と間欠熱、電解質異常から原発性副腎機能低下症を疑った高齢女性の一例
(第17回 日本病院総合診療医学会学術集会, 岐阜, 2018.9.15～9.16)
池崎裕昭、藤田敦子、藤永ゆい、上山貴嗣、小森彩佳、坂本篤彦、林 純

14.インフルエンザB型罹患後に侵襲性肺アスペルギルス症を発症し、VRCZにて救命できた高齢女性の一例
(第88回 日本感染症学会西日本地方会学術集会, 鹿児島, 2018.11.16～11.18)
池崎裕昭、藤田敦子、青戸愛香、伊藤麻衣子、中道真理子、加勢田富士子、三好かほり、坂本篤彦、林 純

15.インフルエンザB型罹患後に侵襲性肺アスペルギルス症を発症し、VRCZにて救命できた超高齢女性の一例
(第18回 日本病院総合診療医学会学術総会, 沖縄, 2019.2.15～2.16)
池崎裕昭、藤田敦子、青戸愛香、伊藤麻衣子、中道真理子、加勢田富士子、三好かほり、坂本篤彦、林 純

16.直接法LDLコレステロール値と高感度CRP値の冠動脈疾患予測因子としての有用性
(第18回 日本病院総合診療医学会学術総会, 沖縄, 2019.2.15～2.16)
池崎裕昭、横田裕哉、Ernst J Schaefer、藍 真澄、村田昌之、古庄憲浩、林 純

17.冠動脈疾患予測因子としてのリポ蛋白の有用性
(第116回 日本内科学会総会・講演会, 名古屋, 2019.4.26～4.28)
池崎裕昭、横田裕哉、藍 真澄、村田昌之、古庄憲浩、林 純

18.Small Dense Low Density Lipoprotein Cholesterol Predict Carotid Intimal Medial Thickness Progression
(第51回 日本動脈硬化学会総会・学術集会, 京都, 2019.7.11～7.12)
Ikezaki H, Furusyo N, Yokota Y, Ai M, Asztalos BF, Murata M, Hayashi J, Schaefer EJ

19.フレイルティに相関する因子の探索
(第20回 日本病院総合診療医学会学術総会, 福岡, 2020.2.21～2.22)
池崎裕昭、小森彩佳、加勢田富士子、坂本篤彦、森 英樹、家森幸男、原 寛、林 純

20.頸動脈内膜中膜複合体の肥厚進展予測因子としてのsmall dense LDLコレステロールの有用性
(第20回 日本病院総合診療医学会学術総会, 福岡, 2020.2.21～2.22)
池崎裕昭、横田裕哉、藍 真澄、Asztalos BF、村田昌之、古庄憲浩、林 純、Schaefer EJ

21.一般住民におけるプレフレイルティ状態に関与する血液検査、生活習慣、食事習慣の解析
(第35回 日本臨床栄養代謝学会学術集会, 京都（web開催）, 2020.2.27～2.28)
池崎裕昭、林 純、原 寛

22.フレイルティに相関する因子の探索
(第62回 日本老年医学会学術集会, 東京, 2020.8.4～8.6)
池崎裕昭、小森彩佳、加勢田富士子、坂本篤彦、森 英樹、家森幸男、原 寛、林 純

23.頸動脈内膜中膜複合体の肥厚進展予測因子としてのsmall dense LDLコレステロールの有用性
(第117回 日本内科学会総会・講演会, 東京, 2020.8.7～8.9)
池崎裕昭、横田裕哉、藍 真澄、Asztalos BF、村田昌之、林 純、Schaefer EJ

24.住民健診受診者における生活習慣病の未診断率と未診断者の検査値の検討
(第23回 日本病院総合診療医学会学術集会, 仙台, 2021.9.18～9.19)
池崎裕昭、中嶋綾子、梅本真紀子、松本佑慈、太田 梓、山嵜 奨、平峯 智、髙山耕治、小川栄一、豊田一弘、村田昌之、林 純、下野信行

25.新型コロナウイルスワクチン接種後の抗体価の推移と副反応の検討
(第29回 日本慢性期医療学会, 横浜, 2021.10.14～10.15)
池崎裕昭、三好かほり、永樂訓三、野村秀幸、原 寛

26.ビタミンD摂取量が脂質20分画と肥満に与える影響の検討－Kyushu and Okinawa Population Studyの結果より
(第53回 日本動脈硬化学会総会・学術集会, 京都, 2021.10.23～10.24)
池崎裕昭、中嶋綾子、古庄憲浩、藍 真澄、岡崎三代、林 純、Ernst J Schaefer

27.新型コロナウイルスワクチン接種後の抗体価の推移と副反応との相関の検討
(第91回 日本感染症学会西日本地方会学術集会, 岐阜, 2021.11.5～11.7)
池崎裕昭、下野信行、野村秀幸

28.新型コロナウイルスワクチン接種後のIgG抗体価の年代間差に関する検討
(第96回 日本感染症学会総会・学術講演会, 川越 （Virtual）, 2022.4.22～4.23)
池崎裕昭、野村秀幸、下野信行

29.新型コロナウイルスワクチン接種半年後のIgG抗体価の評価とワクチン接種効果の検討
(第96回 日本感染症学会総会・学術講演会, 川越 （Virtual）, 2022.4.22～4.23)
池崎裕昭、野村秀幸、下野信行

30.Atherosclerotic cardiovascular disease risk and small dense low-density lipoprotein cholesterol in men, women, African Americans and non-African Americans.
(第54回 日本動脈硬化学会総会・学術集会, 久留米, 2022.7.23～7.24)
池崎裕昭、Ernst J Schaefer、Elise Lim、L Adrienne Cupples、Ching-Ti Liu、Ron C Hoogeveen、Weihua Guan、Michael Tsai、Christie M Ballantyne

31.動脈硬化性心血管疾患のリスク予測因子としてのsmall dense LDLコレステロールの有用性
(第26回 日本病院総合診療医学会学術総会, 宇都宮, 2023.2.18～2.19)
池崎裕昭、Ernst J Schaefer、Elise Lim、L Adrienne Cupples、Ching-Ti Liu、Ron C Hoogeveen、Weihua Guan、Michael Tsai、Christie M Ballantyne

32.非アルコール性脂肪肝（NAFLD）関連遺伝子多型が頸動脈硬化症に与える影響の検討
(第120回 日本内科学会講演会, 東京, 2023.4.14～4.16)
池崎裕昭、江藤義隆、村田昌之、下野信行

33.新型コロナウイルスワクチン接種後のIgG抗体価および細胞性免疫に末梢血ミトコンドリアDNA量が与える影響の検討
(第97回 日本感染症学会総会・学術講演会, 横浜, 2023.4.28～4.30)
池崎裕昭、野村秀幸、下野信行

34.新型コロナウイルスワクチンによる獲得免疫に末梢血ミトコンドリアDNA量が与える影響の検討
(第65回 日本老年医学会学術集会, 横浜, 2023.6.16～6.18)
池崎裕昭、野村秀幸、下野信行

35.非アルコール性脂肪肝（NAFLD）関連遺伝子が動脈硬化の進展に与える影響の検討
(第55回 日本動脈硬化学会総会・学術集会, 宇都宮, 2023.7.8～7.9)
池崎裕昭、江藤義隆、中嶋綾子、村田昌之、下野信行

36.新型コロナウイルスワクチンの追加接種が推奨される対象者像の検討
(第93回 日本感染症学会西日本地方会学術集会, 富山, 2023.11.9～11.11)
池崎裕昭、野村秀幸、下野信行

37.非アルコール性脂肪肝（NAFLD）関連遺伝子多型が頸動脈硬化症に与える影響の検討
(第34回 日本疫学会学術総会, 大津, 2024.1.31～2.2)
池崎裕昭、江藤義隆、中嶋綾子、村田昌之、下野信行

38.mRNAワクチン接種による免疫誘導に末梢血ミトコンドリアDNA量が与える影響の検討
(第121回 日本内科学会講演会, 東京, 2024.4.12～4.14)
池崎裕昭、下野信行、野村秀幸

39.末梢白血球中ミトコンドリアDNA量とフレイルの相関
(第66回 日本老年医学会学術集会, 名古屋, 2024.6.13～6.15)
池崎裕昭、原寛、野村秀幸、下野信行

40.NAFLD関連遺伝子多型が脂質代謝に及ぼす影響の検討
(第56回 日本動脈硬化学会総会・学術集会, 神戸, 2024.7.6～7.7)
池崎裕昭、中嶋綾子、江藤義隆、村田昌行、野村秀幸、下野信行、Schaefer EJ

41.非アルコール性脂肪肝（NAFLD）関連遺伝子が頸動脈プラーク新規発症に与える影響
(第29回 日本病院総合診療医学会学術総会, 東京, 2024.9.7～9.8)
池崎裕昭、江藤義隆、村田昌之、野村秀幸、下野信行

42.癌関連画像検査リスト表示を可能とする外来支援ファイル構築（ファイルメーカーとMSエクセルの比較）
(第39回 日本糖尿病合併症学会, つくば, 2024.10.4～10.5)
池崎裕昭、古賀龍彦、原 祐一、野村秀幸、原 寛

43.非アルコール性脂肪肝疾患（NAFLD）関連遺伝子多型は脂質代謝に影響を及ぼす
(第35回 日本疫学会学術総会, 高知, 2025.2.13～2.14)
池崎裕昭、中嶋綾子、江藤義隆、村田昌之、野村秀幸、下野信行、Schaefer EJ

44.NAFLD関連遺伝子多型が脂質代謝に及ぼす影響の検討
(第30回 日本病院総合診療医学会学術総会, 広島, 2025.2.22～2.24)
池崎裕昭、中嶋綾子、江藤義隆、村田昌行、野村秀幸、下野信行、Schaefer EJ

45.軽症・中等症の高齢COVID-19罹患者における抗ウイルス薬の効果および死亡リスク因子の検討
(第122回 日本内科学会講演会, 大阪, 2024.4.18～4.20)
池崎裕昭、三好かほり、野村秀幸、下野信行

46.軽症・中等症の高齢COVID-19罹患者における死亡リスク因子の検討
(第99回 日本感染症学会総会・学術講演会, 横浜, 2025.5.8～5.10)
池崎裕昭、野村秀幸、下野信行

47.軽症・中等症の高齢COVID-19罹患者における死亡リスク因子の検討
(第67回 日本老年医学会学術講演会, 幕張, 2025.6.27～6.29)
池崎裕昭、野村秀幸、下野信行

48.冠動脈疾患リスク因子の日米人種差比較
(第57回 日本動脈硬化学会総会・学術集会, つくば, 2025.7.5～7.6)
池崎裕昭、中嶋綾子、Yixin Zhang、Ching-Ti Liu、Ron C Hoogeveen、Weihua Guan、Michael Y Tsai、Christie M Ballantyne、下野信行、Schaefer EJ

49.末梢白血球中のミトコンドリアDNA量と脂質代謝の相関
(第31回 日本病院総合診療医学会学術総会, 姫路, 2025.9.27～9.28)
池崎裕昭、中嶋綾子、野村秀幸、下野信行

50.Association between non-alcoholic fatty liver disease risk SNP variants and lipid metabolism
(第70回 日本人類遺伝学会大会, 横浜, 2025.12.17～12.20)
Ikezaki H, Nakashima R, Etoh Y, Shimono N, Schaefer EJ

51.Cardiovascular Disease Risk Factors in Japan versus the United States
(第36回 日本疫学会学術総会・国際疫学会西太平洋地域 合同大会, 長崎, 2026.1.28～1.30)
Ikezaki H, Nakashima R, Zhang Y, Liu CT, Hoogeveen RC, Guan W, Tsai MY, Ballantyne CM, Shimono N, Schaefer EJ

52.高齢糖尿病患者に対するイメグリミンの有効性と安全性の検討
(第32回 日本病院総合診療医学会学術総会, 長崎, 2026.2.22～2.24)
池崎裕昭、髙瀨慶一郎、永樂訓三、中園貴子、藤本弥生、古賀龍彦、野村秀幸、林 純、下野信行

53.高齢糖尿病患者に対するイメグリミンの有効性と安全性の検討
(第36回 日本老年医学会九州地方会, 宮崎, 2026.3.7)
池崎裕昭、髙瀨慶一郎、永樂訓三、中園貴子、藤本弥生、古賀龍彦、野村秀幸、林 純、下野信行

54.高齢糖尿病患者に対するイメグリミンの有効性と安全性の検討
(第123回 日本内科学会講演会, 東京, 2026.4.10～4.12)
池崎裕昭、中嶋綾子、野村秀幸、下野信行

55.オミクロン時代における高齢COVID-19患者の死亡リスク因子の検討
(第100回 日本感染症学会総会・学術講演会, 東京, 2026.5.22～5.24)
池崎裕昭、野村秀幸、下野信行

56.肝機能障害を有する糖尿病患者に対するイメグリミンの有用性と安全性
(第12回肝臓と糖尿病・代謝研究会, 新潟, 2026.6.20)
池崎裕昭、中嶋綾子、髙瀨慶一郎、中園貴子、古賀龍彦、野村秀幸、林純、下野信行

57.高齢糖尿病患者におけるイメグリミンの有効性と安全性の検討
(第58回 日本動脈硬化学会総会・学術集会, 東京, 2026.7.4～7.5)
池崎裕昭、中嶋綾子、髙瀨慶一郎、中園貴子、古賀龍彦、野村秀幸、林純、下野信行

58.small dense LDLコレステロールなどを組み込んだ新たな動脈硬化性心血管疾患発症リスク予測モデルの検証
(第58回 日本動脈硬化学会総会・学術集会, 東京, 2026.7.4～7.5)
池崎裕昭、Zhang Y, Schaefer EJ, Diffenderfer M, Lloyd-Jones D, Hoogeveen RC, Ballantyne CM, Guan W, Tsai MY, Liu CT

1.耐糖能異常の指標としての尿中ミオイノシトールの有用性（第6回 日本病院総合診療医学会学術集会 会長賞受賞講演）
（第6回 日本病院総合診療医学会学術集会, 岐阜, 2013.3.2～3.3）
池崎裕昭、古庄憲浩、岡田享子、居原　毅、林　武生、小川栄一、貝沼茂三郎、岡田享子、村田昌之、林　純

2.耐糖能に関する人種差の検討－Kyushu-Okinawa Population StudyとFramingham Offspring Studyの比較検討－（2017年 日本病院総合診療医学会 学会賞受賞講演）
(第15回 日本病院総合診療医学会学術総会, 東京, 2017.9.14～9.15)
池崎裕昭、藍　真澄、Ernst J Schaefer、男澤聖子、Bela F Asztalos、中嶋克行、Yanhua Zhou、Ching-ti Liu、Paul F Jacques、L Adrienne Cupples、古庄憲浩、林　純

3.C型慢性肝炎患者におけるインターフェロンβ・リバビリン併用療法後の肝癌発症に関与する因子の検討（第10回 福岡県医学会 奨励賞受賞講演）
(第10回 福岡県医学会総会, 福岡, 2018.2.4)
池崎裕昭、野村秀幸、古庄憲浩、小川栄一、梶原英二、高橋和弘、河野　聡、丸山俊博、田辺雄一、佐藤丈顕、中牟田　誠、古藤和浩、東　晃一、道免和文、下田慎治、林　純

4.食事パターンがH.pylori一次除菌療法に与える影響の検討（平成30年度 感染症優秀論文賞 受賞講演）
(第88回 日本感染症学会西日本地方会学術集会, 鹿児島, 2018.11.16～11.18)
池崎裕昭、古庄憲浩、Paul F Jacques、村田昌之、Ernst J Schaefer、瓜田純久、林　純

5.日本人高齢者における新型コロナウイルスワクチン接種後のIgG抗体価に関する検討（第119回 日本内科学会講演会 プレナリーセッション）
(第119回 日本内科学会講演会, 京都, 2022.4.15～4.17)
池崎裕昭、中嶋綾子、原　祐一、林　純、原　寛、野村秀幸、下野信行

6.Impact of peripheral mitochondrial DNA level on immune response after COVID-19 vaccination（第17回 福岡県医学会 奨励賞受賞講演）
（第17回 福岡県医学会総会, 福岡, 2025.1.26）
池崎裕昭、下野信行、野村秀幸

1.Small Dense Low-Density Lipoprotein Cholesterol – a Strong Atherogenic Lipoprotein（会長企画シンポジウム Beyond LDL：動脈硬化性疾患の残余リスクと闘う！）
（第87回 日本循環器学会学術集会, 福岡, 2023.3.10～3.12）
池崎裕昭、古庄憲浩、村田昌之、下野信行、林　純、Schaefer EJ

2.末梢血ミトコンドリアDNA量が免疫能に与える影響の検討（若手・基礎研究ミーティング推薦演題）
（第65回 日本老年医学会学術集会, 横浜, 2023.6.16～6.18）
池崎裕昭、野村秀幸、下野信行

3.動脈硬化性疾患リスクとしてのLDLコレステロールの質と量を考える（シンポジウム 健診データの解析から得られる最新の知見とエビデンス ～LDLコレステロールと動脈硬化～）
（第37回 日本小児脂質研究会, 北九州市, 2023.12.2～12.3）
池崎裕昭

4.クリニカル・クエスチョンが拓くエビデンス －ワクチンの効果を可視化する－（ワークショップ：あなたの日常診療を科学にしよう　Accepted Paper Session－臨床研究の着想から論文アクセプトまでの成功体験を共有する－）
（第98回 日本感染症学会総会・学術講演会, 神戸, 2024.6.27～6.29）
池崎裕昭

5.Atherosclerotic Cardiovascular Disease (ASCVD) Prediction － A Comparison of ASCVD Risk Factors in Epidemiological Studies between Japan and the United States（Special Lecture）
（第56回 日本動脈硬化学会総会・学術集会, 神戸, 2024.7.6～7.7）
池崎裕昭、Ernst J Schaefer、Yixin Zhang、Ching-Ti Liu、Ron C Hoogeveen、Michael Tsai、Weihua Guan、Christie M Ballantyne

1.総合診療医としての疫学研究（特別講演）
(第10回 長九カンファレンス, 長崎, 2017.11.4)
池崎裕昭、古庄憲浩、Schaefer EJ、豊田一弘、小川栄一、村田昌之、林　純

2.働き世代の生活習慣予防に向けた健診の大切さ～脂質検査の重要性～
(労衛研健康啓発セミナー, 福岡市, 2020.2.14)
池崎裕昭

3.Clinical Utility of Small Dense LDL-Cholesterol as a Marker for ASCVD
(Lipid Webinar [on Demand], Lipid Updates vol.4, 2020 Nov.)
Ikezaki H

4.心血管イベント抑制を見据えた脂質異常症診療 ～中性脂肪の意義を再考する～
（博多区内科医会学術講演会, 福岡市, 2022.9.13）
池崎裕昭

5.なぜ高TG血症が残余リスクなのか？LDLの質も考えた脂質異常治療
（直方・鞍手医師会学術講演会, 直方市, 2024.8.26）
池崎裕昭

6.脂質異常症の診かた、考え方 ー総合診療医的視点で脂質異常を診るー
（第81回 九州総合診療セミナー, 福岡市, 2026.9.17）
池崎裕昭

2013年	第6回 日本病院総合診療医学会学術集会 会長賞
2017年	2017年 日本病院総合診療医学会 学会賞
2017年	第10回 福岡県医学会 奨励賞
2018年	平成30年度 日本感染症学会西日本地方会 感染症優秀論文賞（疫学・社会医学的研究部門）
2025年	第17回 福岡県医学会 奨励賞

2014年	第27回 日本心臓財団・バイエル薬品 海外留学助成
2017年	日本病院総合診療医学会 臨床研究助成
2017年	貝原守一医学振興財団 平成29年度研究助成
2019年	臨床研究奨励基金 令和1年度臨床研究助成
2019年	近藤記念医学財団 2019年度学術奨励賞
2020年	文科省科研費 2020年度 若手研究
2021年	新日本先進医療研究財団 令和3年度（第7回）研究助成
2024年	代謝異常治療研究会 令和6年度研究助成
2026年	文科省科研費 2026年度 基盤研究C